Marc E Lippman

SCHOOL OF MEDICINE, MEDICINE

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

Marc E Lippman

• Departments
  SCHOOL OF MEDICINE
  
  MEDICINE
  
  

  Current Appointments:

  Professor

  
  
  

3052439120

Available as Mentor - Not Indicated

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Marc E. Lippman; Jane Cassidy; Margaret Wesley; Robert C. Young

  Erratum: Increasing the response rate to cytotoxic chemotherapy by endocrine means (Journal of Steroid Biochemistry and Molecular Biology (1985) 23:6 (1173-1180))

  Journal of Steroid Biochemistry and Molecular Biology. 2013;133(1):141.
  0

• 2.

  2013

  Marc Lippman; C. Kent Osborne

  Circulating tumor DNA - Ready for prime time?

  New England Journal of Medicine. 2013;368(13):1249-1250.
  0

• 3.

  2012

  Elizabeth Iorns; Jennifer Clarke; Toby Ward; Sonja Dean; Marc Lippman

  Simultaneous analysis of tumor and stromal gene expression profiles from xenograft models

  Breast Cancer Research and Treatment. 2012;131(1):321-324.
  0

• 4.

  2012

  Jenny S. Wong; Elizabeth Iorns; Michelle N. Rheault; Toby M. Ward; Priyanka Rashmi; Ursula Weber; Marc E. Lippman; Christian Faul; Marek Mlodzik; Peter Mundel

  Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilization

  EMBO Journal. 2012;31(4):1028-1040.
  0

• 5.

  2012

  Nicole L. Simone; Tu Dan; Joanna Shih; Sharon L. Smith; Linda Sciuto; Elena Lita; Marc E. Lippman; Eli Glatstein; Sandra M. Swain; David N. Danforth; et al.

  Twenty-five year results of the national cancer institute randomized breast conservation trial

  Breast Cancer Research and Treatment. 2012;132(1):197-203.
  5

• 6.

  2012

  Marc Lippman

  Chaos theory and a career in medicine.

  Endocrine-related cancer. 2012;19(1):P1-3.
  0

• 7.

  2012

  T M Ward; E Iorns; X Liu; N Hoe; P Kim; S Singh; S Dean; A-M Jegg; M Gallas; C Rodriguez; et al.

  Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5

  Oncogene. 2012.
  2

• 8.

  2012

  Elizabeth Iorns; Toby M. Ward; Sonja Dean; Anna Jegg; Dafydd Thomas; Nirupa Murugaesu; David Sims; Costas Mitsopoulos; Kerry Fenwick; Iwanka Kozarewa; et al.

  Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor

  Breast Cancer Research and Treatment. 2012;135(1):79-91.
  2

• 9.

  2012

  Matthew J. Sikora; Viktoriya Strumba; Marc E. Lippman; Michael D. Johnson; James M. Rae

  Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation

  Breast Cancer Research and Treatment. 2012;134(3):1027-1039.
  3

• 10.

  2012

  Elizabeth Iorns; Katherine Drews-Elger; Toby M. Ward; Sonja Dean; Jennifer Clarke; Deborah Berry; Dorraya El Ashry; Marc Lippman

  A New Mouse Model for the Study of Human Breast Cancer Metastasis

  PLoS ONE. 2012;7(10).
  0

• 11.

  2011

  Marc E. Lippman

  Changes in leadership of breast cancer research and treatment

  Breast Cancer Research and Treatment. 2011;125(3):605.
  0

• 12.

  2011

  Marc E. Lippman; Stephen Ethier; Daniel F. Hayes

  Erratum: Editorial: Cost-effective analyses in breast cancer research and treatment (Breast Cancer Research and Treatment (2009) 115( 221-222) DOI: 10.1007/s10549-009-0414-1)

  Breast Cancer Research and Treatment. 2011;129(1):293.
  0

• 13.

  2010

  H.J. Hnatyszyn; M. Liu; A. Hilger; L. Herbert; C.R. Gomez-Fernandez; M. Jorda; D. Thomas; J.M. Rae; D. El-Ashry; M.E. Lippman

  Correlation of GREB1 mRNA with protein expression in breast cancer: Validation of a novel GREB1 monoclonal antibody

  Breast Cancer Research and Treatment. 2010;122(2):371-380.
  6

• 14.

  2010

  Elizabeth Iorns; H. James Hnatyszyn; Pearl Seo; Jennifer Clarke; Toby Ward; Marc Lippman

  The role of SATB1 in breast cancer pathogenesis

  Journal of the National Cancer Institute. 2010;102(16):1284-1296.
  21

• 15.

  2010

  Elizabeth Iorns; H. James Hnatyszyn; Pearl Seo; Jennifer Clarke; Toby Ward; Marc E. Lippman

  Response

  Journal of the National Cancer Institute. 2010;102(24):1880-1881.
  0

• 16.

  2009

  Matthew J. Sikora; Kevin E. Cordero; Jose M. Larios; Michael D. Johnson; Marc E. Lippman; James M. Rae

  The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: Implications for aromatase inhibitor resistance

  Breast Cancer Research and Treatment. 2009;115(2):289-296.
  22

• 17.

  2009

  Shuraila F. Zerp; Rianne Stoter; Gitta Kuipers; Dajun Yang; Marc E. Lippman; Wim J. van Blitterswijk; Harry Bartelink; Rogier Rooswinkel; Vincent Lafleur; et al.

  AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis

  Radiation Oncology. 2009;4(1):47.
  18

• 18.

  2009

  Marc E. Lippman; Stephen Ethier; Daniel F. Hayes

  Cost-effective analyses in Breast Cancer Research and Treatment

  Breast Cancer Research and Treatment. 2009;115(2):221-222.
  0

• 19.

  2008

  Jianjun Yu; Jindan Yu; Kevin E. Cordero; Michael D. Johnson; Debashis Ghosh; James M. Rae; Arul M. Chinnaiyan; Marc E. Lippman

  A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival

  Neoplasia. 2008;10(1):79-88.
  19

• 20.

  2008

  Marc E Lippman; James M Rae; Arul M Chinnaiyan

  An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor status.

  Transactions of the American Clinical and Climatological Association. 2008;119:77-90; discussion 90-92.
  6

• 21.

  2007

  Janice M. Walshe; Arlene W. Berman; Ujala Vatas; Seth M. Steinberg; William F. Anderson; Marc E. Lippman; Sandra M. Swain

  A prospective study of adjuvant CMF in males with node positive breast cancer: 20-Year follow-up

  Breast Cancer Research and Treatment. 2007;103(2):177-183.
  13

• 22.

  2006

  James M. Rae; Michael D. Johnson; Kevin E. Cordero; Joshua O. Scheys; José M. Larios; Marco M. Gottardis; Kenneth J. Pienta; Marc E. Lippman

  GREBI is a novel androgen-regulated gene required for prostate cancer growth

  Prostate. 2006;66(8):886-894.
  17

• 23.

  2006

  Chad J. Creighton; Kevin E. Cordero; Jose M. Larios; Rebecca S. Miller; Michael D. Johnson; Arul M. Chinnaiyan; Marc E. Lippman; James M. Rae

  Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors

  Genome Biology. 2006;7(4).
  57

• 24.

  2006

  Marc E. Lippman; Steven R. Cummings; Damon P. Disch; John L. Mershon; Sherie A. Dowsett; Jane A. Cauley; Silvana Martino

  Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk

  Clinical Cancer Research. 2006;12(17):5242-5247.
  25

• 25.

  2006

  Daniel F. Hayes; Stephen Ethier; Marc E. Lippman

  New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

  Breast Cancer Research and Treatment. 2006;100(2):237-238.
  22

• 26.

  2006

  Richard M. Neve; Koei Chin; Jane Fridlyand; Jennifer Yeh; Frederick L. Baehner; Tea Fevr; Laura Clark; Nora Bayani; Jean-Philippe Coppe; Frances Tong; et al.

  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

  Cancer Cell. 2006;10(6):515-527.
  781

• 27.

  2005

  Liang Xu; Dajun Yang; Shaomeng Wang; Wenhua Tang; Meilan Liu; Mary Davis; Jianyong Chen; James M. Rae; Theodore Lawrence; Marc E. Lippman

  (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate cancer

  Molecular Cancer Therapeutics. 2005;4(2):197-205.
  73

• 28.

  2005

  Marc E. Lippman; Chris Benz; Arul Chinnaiyan; David Flockhart; Adrian Harris; Clifford Hudis; C. Kent Osborne; Michael F. Press; James Rae; George W. Sledge; et al.

  Consensus statement: Expedition Inspiration 2004 Breast Cancer Symposium 'Breast Cancer - The Development and Validation of New Therapeutics'

  Breast Cancer Research and Treatment. 2005;90(1):1-3.
  2

• 29.

  2005

  Emanuel F. Petricoin III; Verena E. Bichsel; Valerie S. Calvert; Virginia Espina; Mary Winters; Lynn Young; Claudio Belluco; Bruce J. Trock; Marc Lippman; et al.

  Mapping molecular networks using proteomics: A vision for patient-tailored combination therapy

  Journal of Clinical Oncology. 2005;23(15):3614-3621.
  99

• 30.

  2005

  Puneeth Iyengar; Virginia Espina; Terence W. Williams; Ying Lin; David Berry; Linda A. Jelicks; Hyangkyu Lee; Karla Temple; Reed Graves; Jeffrey Pollard; et al.

  Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment

  Journal of Clinical Investigation. 2005;115(5):1163-1176.
  87

• 31.

  2005

  James M. Rae; Michael D. Johnson; Joshua O. Scheys; Kevin E. Cordero; José M. Larios; Marc E. Lippman

  GREB1 is a critical regulator of hormone dependent breast cancer growth

  Breast Cancer Research and Treatment. 2005;92(2):141-149.
  77

• 32.

  2005

  Claudine Isaacs; Rebecca Slack; Edmund Gehan; Karen Ballen; Ralph Boccia; Ellen Areman; Ruthie Kramer; Daniel F. Hayes; Herbert Herscowitz; Marc Lippman

  A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

  Breast Cancer Research and Treatment. 2005;93(2):125-134.
  2

• 33.

  2005

  O. Abe; R. Abe; K. Enomoto; K. Kikuchi; H. Koyama; H. Masuda; Y. Nomura; K. Sakai; K. Sugimachi; T. Tominaga; et al.

  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  Lancet. 2005;366(9503):2087-2106.
  1675

• 34.

  2004

  James M. Rae; Marc E. Lippman

  Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors

  Breast Cancer Research and Treatment. 2004;83(2):99-107.
  18

• 35.

  2004

  Zaneta Nikolovska-Coleska; Liang Xu; Zengjian Hu; York Tomita; Peng Li; Peter P. Roller; Renxiao Wang; Xueliang Fang; Ribo Guo; Manchao Zhang; et al.

  Discovery of Embelin as a Cell-Permeable, Small-Molecular Weight Inhibitor of XIAP through Structure-Based Computational Screening of a Traditional Herbal Medicine Three-Dimensional Structure Database

  Journal of Medicinal Chemistry. 2004;47(10):2430-2440.
  158

• 36.

  2004

  J. Marshall; H. Chen; D. Yang; M. Figueira; K.B. Bouker; Y. Ling; M. Lippman; S.R. Frankel; D.F. Hayes

  A phase I trial of a Bcl-2 antisense (G3139) and weekly docetaxel in patients with advanced breast cancer and other solid tumors

  Annals of Oncology. 2004;15(8):1274-1283.
  51

• 37.

  2004

  James M. Rae; Joshua O. Scheys; Kim M. Clark; Robert B. Chadwick; Michael C. Kiefer; Marc E. Lippman

  EGFR and EGFRvIII expression in primary breast cancer and cell lines

  Breast Cancer Research and Treatment. 2004;87(1):87-95.
  25

• 38.

  2004

  Jennifer A. Low; Arlene W. Berman; Seth M. Steinberg; David N. Danforth; Marc E. Lippman; Sandra M. Swain

  Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

  Journal of Clinical Oncology. 2004;22(20):4067-4074.
  92

• 39.

  2004

  Angus M. Tester; Mark Waltham; Se-Jeong Oh; Seog-Nyeon Bae; Margaret M. Bills; Emma C. Walker; Francis G. Kern; William G. Stetler-Stevenson; Marc E. Lippman; Erik W. Thompson

  Pro-Matrix Metalloproteinase-2 Transfection Increases Orthotopic Primary Growth and Experimental Metastasis of MDA-MB-231 Human Breast Cancer Cells in Nude Mice

  Cancer Research. 2004;64(2):652-658.
  46

• 40.

  2003

  Chandan Kumar-Sinha; Kathleen Woods Ignatoski; Marc E. Lippman; Stephen P. Ethier; Arul M. Chinnaiyan

  Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis

  Cancer Research. 2003;63(1):132-139.
  128

• 41.

  2003

  Christopher Benz; Gary Clark; Suzanne Conzen; Ronald Dorn; Suzanne Fuqua; Julie Gralow; Geoffrey Greene; Ruth Heimann; Samuel Hellman; Marc Lippman; et al.

  Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002

  Breast Cancer Research and Treatment. 2003;78(1):127-131.
  0

• 42.

  2003

  Harry Bartelink; Christopher Benz; Don Cleveland; Ronald Dorn; Julie Gralow; William J. Gradishar; Kathleen Grant; Ruth Heimann; Samuel Hellman; Clifford Hudis; et al.

  Expedition Inspiration Fund for Breast Cancer Research Meeting 2003

  Breast Cancer Research and Treatment. 2003;80(2):139-144.
  0

• 43.

  2003

  Wenchi Liang; William F. Lawrence; Caroline B. Burnett; Yi-Ting Hwang; Matthew Freedman; Bruce J. Trock; Jeanne S. Mandelblatt; Marc E. Lippman

  Acceptability of diagnostic tests for breast cancer

  Breast Cancer Research and Treatment. 2003;79(2):199-206.
  10

• 44.

  2003

  James M. Rae; Kevin E. Cordero; Joshua O. Scheys; Marc E. Lippman; David A. Flockhart; Michael D. Johnson

  Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples

  Pharmacogenetics. 2003;13(8):501-507.
  39

• 45.

  2003

  Matthew M. Poggi; David N. Danforth; Linda C. Sciuto; Sharon L. Smith; Seth M. Steinberg; David J. Liewehr; Cynthia Menard; Marc E. Lippman; Allen S. Lichter; Rosemary M. Altemus

  Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute randomized trial

  Cancer. 2003;98(4):697-702.
  186

• 46.

  2003

  Shaomeng Wang; Dajun Yang; Marc E. Lippman

  Targeting Bcl-2 and Bcl-X_L with Nonpeptidic Small-Molecule Antagonists

  Seminars in Oncology. 2003;30(5 SUPPL. 16):133-142.
  109

• 47.

  2002

  Matthew Ellis; Natalie Davis; Andrew Coop; Minetta Liu; Lisa Schumaker; Richard Y. Lee; Rujirutana Srikanchana; Chris G. Russell; Baljit Singh; William R. Miller; et al.

  Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses

  Clinical Cancer Research. 2002;8(5):1155-1166.
  73

• 48.

  2002

  Kenneth R. Meehan; Rebecca Slack; Edmund Gehan; Herbert B. Herscowitz; Ellen M. Areman; Mark Ebadi; Mitchell S. Cairo; Marc E. Lippman

  Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients

  Journal of Hematotherapy and Stem Cell Research. 2002;11(2):415-421.
  4

• 49.

  2002

  Leena Hilakivi-Clarke; Elisabeth Cho; Ana Cabanes; Sonia DeAssis; Susan Olivo; William Helferich; Marc E. Lippman; Robert Clarke

  Dietary modulation of pregnancy estrogen levels and breast cancer risk among female rat offspring

  Clinical Cancer Research. 2002;8(11):3601-3610.
  47

• 50.

  2001

  J.M. Rae; M.D. Johnson; M.E. Lippman; D.A. Flockhart

  Microarray analysis of drug metabolizing enzyme induction in primary hepatocyte cultures

  Clinical Pharmacology and Therapeutics. 2001;69(2):P64.
  0

• 51.

  2001

  M. Lippman

  The epidermal growth factor receptor family of growth factors and ligands as targets for anticancer therapy

  Endocrine-Related Cancer. 2001;8(1):1.
  0

• 52.

  2001

  J.A. Cauley; L. Norton; M.E. Lippman; S. Eckert; K.A. Krueger; D.W. Purdie; J. Farrerons; A. Karasik; D. Mellstrom; K.W. Ng; et al.

  Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial

  Breast Cancer Research and Treatment. 2001;65(2):125-134.
  460

• 53.

  2001

  James M. Rae; Michael D. Johnson; Marc E. Lippman; David A. Flockhart

  Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: Studies with cDNA and oligonucleotide expression arrays

  Journal of Pharmacology and Experimental Therapeutics. 2001;299(3):849-857.
  150

• 54.

  2001

  X. Yang; L.L. Wei; C. Tang; R. Slack; S. Mueller; M.E. Lippman

  Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells

  Cancer Research. 2001;61(13):5284-5288.
  84

• 55.

  2001

  Christopher C. Benz; Leena Hilakivi-Clarke; Suzanne Conzen; Ronald V. Dorn; Gini F. Fleming; Kathleen Grant; Geoffrey Greene; Samuel Hellman; Craig Henderson; Robert Hoover; et al.

  Expedition inspiration consensus 2001

  Breast Cancer Research and Treatment. 2001;70(3):213-219.
  0

• 56.

  2001

  Matthew Freedman; Javier San Martin; John O'Gorman; Stephen Eckert; Marc E. Lippman; Shih-Chung B. Lo; Erin L. Walls; Jianchao Zeng

  Digitized mammography: A clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo

  Journal of the National Cancer Institute. 2001;93(1):51-56.
  104

• 57.

  2001

  M.E. Lippman; K.A. Krueger; S. Eckert; A. Sashegyi; E.L. Walls; S. Jamal; J.A. Cauley; S.R. Cummings

  Indicators of lifetime estrogen exposure: Effect on breast cancer incidence and interaction with Raloxifene therapy in the multiple outcomes of Raloxifene evaluation study participants

  Journal of Clinical Oncology. 2001;19(12):3111-3116.
  82

• 58.

  2001

  Marc E. Lippman; Daniel F. Hayes

  Adjuvant therapy for all patients with breast cancer?

  Journal of the National Cancer Institute. 2001;93(2):80-82.
  26

• 59.

  2000

  A.J. Hayes; W.-Q. Huang; J. Yu; P.C. Maisonpierre; A. Liu; F.G. Kern; M.E. Lippman; S.W. McLeskey; L.-Y. Li

  Expression and function of angiopoietin-1 in breast cancer

  British Journal of Cancer. 2000;83(9):1154-1160.
  94

• 60.

  2000

  X. Yang; L. Wei; C. Tang; R. Slack; E. Montgomery; M. Lippman

  KAI1 protein is down-regulated during the progression of human breast cancer

  Clinical Cancer Research. 2000;6(9):3424-3429.
  51

• 61.

  2000

  Said M. Baidas; Eric P. Winer; Gini F. Fleming; Lyndsay Harris; James M. Pluda; Jeanette G. Crawford; Hideko Yamauchi; Claudine Isaacs; John Hanfelt; Mariella Tefft; et al.

  Phase II evaluation of thalidomide in patients with metastatic breast cancer

  Journal of Clinical Oncology. 2000;18(14):2710-2717.
  93

• 62.

  2000

  M. Lippman

  Endocrine-related cancer: Editorial

  Endocrine-Related Cancer. 2000;7(1):1.
  0

• 63.

  2000

  Careen K. Tang; Xiao-Qi Gong; David K. Moscatello; Albert J. Wong; Marc E. Lippman

  Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer

  Cancer Research. 2000;60(11):3081-3087.
  103

• 64.

  2000

  Parul Bhargava; Glenn M. Eisen; Daniel A. Holterman; Norio Azumi; Dan-Paul Hartmann; John J. Hanfelt; Stanley B. Benjamin; Marc E. Lippman; Elizabeth A. Montgomery

  Endoscopic mapping and surrogate markers for better surveillance in Barrett esophagus: A study of 700 biopsy specimens

  American Journal of Clinical Pathology. 2000;114(4):552-563.
  16

• 65.

  2000

  Raya Mandler; Chuanchu Wu; Edward A. Sausville; Alexis J. Roettinger; David J. Newman; David K. Ho; C. Richter King; Dajun Yang; Marc E. Lippman; Nicholas F. Landolfi; et al.

  Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines

  Journal of the National Cancer Institute. 2000;92(19):1573-1581.
  47

• 66.

  2000

  M.E. Lippman

  High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer

  New England Journal of Medicine. 2000;342(15):1119-1120.
  37

• 67.

  2000

  Y.-H. Kuo; S.R. Cummings; D. Grady; D. Black; S. Eckert; K.A. Krueger; T. Nickelsen; J.E. Glusman; E. Lilly; T.J. Powles; et al.

  Estrogen-receptor status in breast cancer [4] (multiple letters)

  Journal of the American Medical Association. 2000;283(3):338-339.
  1

• 68.

  2000

  A.L. Hayes; L.Y. Li; M.E. Lippman

  Anti-vascular therapy: A new approach to cancer treatment

  Western Journal of Medicine. 2000;172(1):39-42.
  8

• 69.

  1999

  Careen K. Tang; Xiao-Zheng Wu Concepcion; Melissa Milan; Xiaoqi Gong; Elizabeth Montgomery; Marc E. Lippman

  Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor- positive breast cancer cells inhibits proliferation both in vitro and in vivo

  Cancer Research. 1999;59(20):5315-5322.
  56

• 70.

  1999

  G.M. Eisen; E.A. Montgomery; N. Azumi; D.-P. Hartmann; P. Bhargava; M. Lippman; S.B. Benjamin

  Qualitative mapping of Barrett's metaplasia: A prerequisite for intervention trials

  Gastrointestinal Endoscopy. 1999;50(6):814-818.
  31

• 71.

  1999

  K.R. Meehan; B. Arun; E.A. Gehan; B. Berberian; V. Sulica; E.M. Areman; A. Mazumder; M.E. Lippman

  Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

  Bone Marrow Transplantation. 1999;23(7):667-673.
  23

• 72.

  1999

  Xiaohong Yang; Marc E. Lippman

  BRCA1 and BRCA2 in breast cancer

  Breast Cancer Research and Treatment. 1999;54(1):1-10.
  40

• 73.

  1999

  Leena Hilakivi-Clarke; Robert Clarke; Marc Lippman

  The influence of maternal diet on breast cancer risk among female offspring

  Nutrition. 1999;15(5):392-401.
  27

• 74.

  1999

  Yifan Zhai; Jingyi Yu; Luisa Iruela-Arispe; Wei-Qun Huang; Zheng Wang; Andrew J. Hayes; Jiamo Lu; Gongwei Jiang; Lorena Rojas; Marc E. Lippman; et al.

  Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily

  International Journal of Cancer. 1999;82(1):131-136.
  54

• 75.

  1999

  Steven R. Cummings; Stephen Eckert; Kathryn A. Krueger; Deborah Grady; Trevor J. Powles; Jane A. Cauley; Larry Norton; Thomas Nickelsen; Nina H. Bjarnason; Monica Morrow; et al.

  The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial

  Journal of the American Medical Association. 1999;281(23):2189-2197.
  1419

• 76.

  1999

  M.D. Johnson; J.A. Torri; M.E. Lippman; R.B. Dickson

  Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness

  Experimental Cell Research. 1999;247(1):105-113.
  49

• 77.

  1999

  Caterina Bianco; Subha Kannan; Marta De Santis; Masaharu Seno; Careen K. Tang; Isabel Martinez-Lacaci; Nancy Kim; Brenda Wallace-Jones; Marc E. Lippman; et al.

  Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor

  Journal of Biological Chemistry. 1999;274(13):8624-8629.
  53

• 78.

  1999

  A.J. Hayes; L.Y. Li; M.E. Lippman

  Science, medicine, and the future. Antivascular therapy: A new approach to cancer treatment

  British Medical Journal. 1999;318(7187):853-856.
  43

• 79.

  1999

  Andrew J. Hayes; Wei-Qun Huang; Jamie Mallah; Dajun Yang; Marc E. Lippman; Lu-Yuan Li

  Angiopoietin-1 and its receptor tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells

  Microvascular Research. 1999;58(3):224-237.
  133

• 80.

  1998

  Dajun Yang; Chien-Tsun Kuan; Jeniffer Payne; Ako Kihara; Ann Murray; Ling-Mei Wang; Maurizio Alimandi; Jacalyn H. Pierce; Ira Pastan; Marc E. Lippman

  Recombinant heregulin-pseudornonas exotoxin fusion proteins: Interactions with the heregulin receptors and antitumor activity in vivo

  Clinical Cancer Research. 1998;4(4):993-1004.
  16

• 81.

  1998

  Careen K. Tang; David J. Goldstein; Jennifer Payne; Frank Czubayko; Maurizio Alimandi; Ling-Mei Wang; Jacalyn H. Pierce; Marc E. Lippman

  ErbB-4 ribozymes abolish neuregulin-induced mitogenesis

  Cancer Research. 1998;58(15):3415-3422.
  22

• 82.

  1998

  Todd C. Skaar; Sarada C. Prasad; Sheri Sharareh; Marc E. Lippman; Nils Brünner; Robert Clarke

  Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

  Journal of Steroid Biochemistry and Molecular Biology. 1998;67(5-6):391-402.
  41

• 83.

  1998

  Yifan Zhai; Ribo Guo; Tsui-Ling Hsu; Guo-Liang Yu; Jian Ni; Byoung S. Kwon; Gong-Wei Jiang; Jiamo Lu; Jie Tan; Meena Ugustus; et al.

  LIGHT, a novel ligand for lymphotoxin β receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer

  Journal of Clinical Investigation. 1998;102(6):1142-1151.
  178

• 84.

  1998

  O. Abe; R. Abe; K. Enomoto; K. Kikuchi; H. Koyama; Y. Nomura; K. Sakai; K. Sugimachi; T. Tominaga; J. Uchino; et al.

  Tamoxifen for early breast cancer: An overview of the randomised trials

  Lancet. 1998;351(9114):1451-1467.
  2911

• 85.

  1998

  Soonmyung Paik; John Bryant; Chanheun Park; Bernard Fisher; Elizabeth Tan-Chiu; David Hyams; Edwin R. Fisher; Marc E. Lippman; D. Lawrence Wickerham; Norman Wolmark

  erbB-2 and response to doxorubicin in patients with axillary lymph node- positive, hormone receptor-negative breast cancer

  Journal of the National Cancer Institute. 1998;90(18):1361-1370.
  519

• 86.

  1998

  C. Giani; A. Pinchera; A. Rasmussen; P. Fierabracci; R. Bonacci; D. Campani; G. Bevilacqua; B. Trock; M.E. Lippman; et al.

  Stromal IGF-II messenger RNA in breast cancer: Relationship with progesterone receptor expressed by malignant epithelial cells

  Journal of Endocrinological Investigation. 1998;21(3):160-165.
  10

• 87.

  1998

  David N. Danforth Jr.; JoAnne Zujewski; Joyce O'Shaughnessy; David Riseberg; Seth M. Steinberg; Nanette McAtee; Marianne Noone; Catherine Chow; Usha Chaudhry; et al.

  Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

  Annals of Surgical Oncology. 1998;5(2):150-158.
  34

• 88.

  1997

  G.M. Eisen; E.A. Montgomery; N. Azumi; D.P. Hartmann; P. Bhargava; M. Lippman; S.B. Benjamin

  Phase I trial-qualitative mapping of barrett metaplasia: A prrequisite for intervention trials

  Gastrointestinal Endoscopy. 1997;45(4):AB68.
  0

• 89.

  1997

  K.R. Meehan; U.N. Verma; R. Cahill; S. Frankel; E.M. Areman; R.A. Sacher; R. Foelber; C. Rajagopal; E.A. Gehan; et al.

  Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: Investigation of dose level with clinical correlates

  Bone Marrow Transplantation. 1997;20(8):643-651.
  23

• 90.

  1997

  Dorraya El-Ashry; David L. Miller; Samir Kharbanda; Marc E. Lippman; Francis G. Kern

  Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

  Oncogene. 1997;15(4):423-435.
  73

• 91.

  1997

  Maurizio Alimandi; Ling-Mei Wang; Donald Bottaro; Chong-Chou Lee; Angera Kuo; Mark Frankel; Paolo Fedi; Careen Tang; Marc Lippman; Jacalyn H. Pierce

  Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

  EMBO Journal. 1997;16(18):5608-5617.
  96

• 92.

  1997

  Leena Hilakivi-Clarke; Robert Clarke; Ighovie Onojafe; Margarita Raygada; Elizabeth Cho; Marc Lippman

  A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring

  Proceedings of the National Academy of Sciences of the United States of America. 1997;94(17):9372-9377.
  137

• 93.

  1997

  Donna Shattuck-Eidens; Arnold Oliphant; Melody McClure; Celeste McBride; Jamila Gupte; Todd Rubano; Dmitry Pruss; Sean V. Tavtigian; David H.-F. Teng; Nils Adey; et al.

  BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing

  Journal of the American Medical Association. 1997;278(15):1242-1250.
  281

• 94.

  1997

  Christian F. Singer; Audrey Rasmussen; Marc E. Lippman; Kevin J. Cullen

  Coexpression of Stromelysin-3 and Insulin-Like Growth Factor II in Tumors of Ectodermal, Mesodermal, and Endodermal Origin: Indicator of a Fetal Cell Phenotype

  Journal of Clinical Endocrinology and Metabolism. 1997;82(6):1917-1922.
  11

• 95.

  1996

  S.M. Swain; J. Rowland; K. Weinfurt; C. Berg; M.E. Lippman; L. Walton; E. Egan; D. King; I. Spertus; S.F. Honig

  Intensive outpatient adjuvant therapy for breast cancer: Results of dose escalation and quality of life

  Journal of Clinical Oncology. 1996;14(5):1565-1572.
  28

• 96.

  1996

  Miguel Saceda; Thomas W. Grunt; Ramon Colomer; Marc E. Lippman; Ruth Lupu; Mary Beth Martin

  Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines

  Endocrinology. 1996;137(10):4322-4330.
  32

• 97.

  1996

  Matthew J. C. Ellis; Brett A. Leav; Zejia Yang; Audrey Rasmussen; Amelia Pearce; James A. Zweibel; Marc E. Lippman; Kevin J. Cullen

  Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells

  Molecular Endocrinology. 1996;10(3):286-297.
  59

• 98.

  1996

  S.W. McLeskey; L. Zhang; B.J. Trock; S. Kharbanda; Y. Liu; M.M. Gottardis; M.E. Lippman; F.G. Kern

  Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells

  British Journal of Cancer. 1996;73(9):1053-1062.
  39

• 99.

  1996

  Sandra W. McLeskey; Lurong Zhang; Samir Kharbanda; Junichi Kurebayashi; Marc E. Lippman; Robert B. Dickson; Francis G. Kern

  Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis

  Breast Cancer Research and Treatment. 1996;39(1):103-117.
  36

• 100.

  1996

  R.B. Dickson; M.E. Lippman

  New approaches in the therapy of breast cancer - Introduction

  Breast Cancer Research and Treatment. 1996;38(1):1-2.
  5

• 101.

  1996

  Francis G. Kern; Marc E. Lippman

  The role of angiogenic growth factors in breast cancer progression

  Cancer and Metastasis Reviews. 1996;15(2):213-219.
  14

• 102.

  1996

  Dorraya El-Ashry; Susan A. Chrysogelos; Marc E. Lippman; Francis G. Kern

  Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes

  Journal of Steroid Biochemistry and Molecular Biology. 1996;59(3-4):261-269.
  49

• 103.

  1996

  R. Clarke; T. Skaar; F. Leonessa; B. Brankin; M. James; N. Brünner; M.E. Lippman

  Acquisition of an antiestrogen-resistant phenotype in breast cancer: role of cellular and molecular mechanisms.

  Cancer treatment and research. 1996;87:263-283.
  6

• 104.

  1996

  Leena Hilakivi-Clarke; Ighovie Onojafe; Margarita Raygada; Elizabeth Cho; Robert Clarke; Marc E. Lippman

  Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy

  Journal of the National Cancer Institute. 1996;88(24):1821-1827.
  50

• 105.

  1995

  M.M. Gottardis; M. Saceda; P. Garcia-Morales; Y.-K. Fung; H. Solomon; P.F. Sholler; M.E. Lippman; M.B. Martin

  Regulation of retinoblastoma gene expression in hormone-dependent breast cancer

  Endocrinology. 1995;136(12):5659-5665.
  13

• 106.

  1995

  R.B. Dickson; M.E. Lippman

  Growth factors in breast cancer

  Endocrine Reviews. 1995;16(5):559-589.
  320

• 107.

  1995

  M.E. Lippman

  Erratum: How should we manage breast cancer in the breast, or buddy, can you paradigm? (Journal of the National Cancer Institute (1995) 87 (3-4))

  Journal of the National Cancer Institute. 1995;87(8):610.
  0

• 108.

  1995

  M.E. Lippman

  Erratum: How should we manage breast cancer in the breast, or buddy, can you paradigm? (Journal of the National Cancer Institute (1995) 87 (3-4))

  Journal of the National Cancer Institute. 1995;87(7):540.
  0

• 109.

  1995

  P.V. Elizalde; F.K. Guerra; M. Gravano; C. Lanari; M.E. Lippman; E.H. Charreau; R. Lupu

  Correlation of TGF-β₁ expression with medroxiprogesterone acetate responsiveness in mouse mammary adenocarcinomas

  Cancer Investigation. 1995;13(2):173-180.
  5

• 110.

  1995

  Jesús Ruiz-Cabello; Kirsten Berghmans; Ofer Kaplan; Marc E. Lippman; Robert Clarke; Jack S. Cohen

  Hormone dependence of breast cancer cells and the effects of tamoxifen and estrogen:³¹P NMR studies

  Breast Cancer Research and Treatment. 1995;33(3):209-217.
  11

• 111.

  1995

  Joan A. Jacobson; David N. Danforth; Kenneth H. Cowan; Teresa D'Angelo; Seth M. Steinberg; Lori Pierce; Marc E. Lippman; Allen S. Lichter; Eli Glatstein; Paul Okunieff

  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer

  New England Journal of Medicine. 1995;332(14):907-911.
  560

• 112.

  1995

  M. Lippman; G. Calabrese

  More on smoking superheroes [6]

  New England Journal of Medicine. 1995;333(11):734-735.
  0

• 113.

  1995

  C. Singer; A. Rasmussen; H.S. Smith; M.E. Lippman; H.T. Lynch; K.J. Cullen

  Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: Evidence for paracrine function

  Cancer Research. 1995;55(11):2448-2454.
  116

• 114.

  1995

  S.M. Swain; B. Parker; A. Wellstein; M.E. Lippman; C. Steakley; R. DeLap

  Phase I trial of pentosan polysulfate

  Investigational New Drugs. 1995;13(1):55-62.
  12

• 115.

  1995

  L. Hilakivi-Clarke; E. Cho; M. Raygada; I. Onojafe; R. Clarke; M.E. Lippman

  Early life affects the risk of developing breast cancer

  Annals of the New York Academy of Sciences. 1995;768:327-330.
  6

• 116.

  1995

  Marc E. Lippman

  How should we manage breast cancer in the breast, or buddy, can you paradigm?

  Journal of the National Cancer Institute. 1995;87(1):3-4.
  8

• 117.

  1994

  D. Eliyahu; S. Evans; N. Rosen; S. Eliyahu; J. Zwiebel; S. Paik; M. Lippman

  p53Val135 temperature sensitive mutant suppresses growth of human breast cancer cells

  Breast Cancer Research and Treatment. 1994;30(2):167-177.
  4

• 118.

  1994

  Sandra W. McLeskey; Ivan Y. F. Ding; Marc E. Lippman; Francis G. Kern

  MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands

  Cancer Research. 1994;54(2):523-530.
  75

• 119.

  1994

  L. Hilakivi-Clarke; R. Clarke; M.E. Lippman

  Perinatal factors increase breast cancer risk

  Breast Cancer Research and Treatment. 1994;31(2-3):273-284.
  21

• 120.

  1994

  S. Paik; D.P. Hartmann; R.B. Dickson; M.E. Lippman

  Antiestrogen resistance in ER positive breast cancer cells

  Breast Cancer Research and Treatment. 1994;31(2-3):301-307.
  21

• 121.

  1994

  Dorraya El-Ashry; Marc E. Lippman

  Molecular biology of breast carcinoma

  World Journal of Surgery. 1994;18(1):12-20.
  22

• 122.

  1994

  K. Porter-Jordan; M.E. Lippman

  Overview of the biologic markers of breast cancer

  Hematology/Oncology Clinics of North America. 1994;8(1):73-100.
  73

• 123.

  1994

  L. Hilakivi-Clarke; J. Rowland; R. Clarke; M.E. Lippman

  Psychosocial factors in the development and progression of breast cancer

  Breast Cancer Research and Treatment. 1994;29(2):141-160.
  62

• 124.

  1994

  E.W. Thompson; J. Torri; M. Sabol; C.L. Sommers; S. Byers; E.M. Valverius; G.R. Martin; M.E. Lippman; M.R. Stampfer; et al.

  Oncogene-induced basement membrane invasiveness in human mammary epithelial cells

  Clinical and Experimental Metastasis. 1994;12(3):181-194.
  44

• 125.

  1994

  Y.E. Shi; Y.E. Liu; M.E. Lippman; R.B. Dickson

  Progestins and antiprogestins in mammary tumour growth and metastasis

  Human Reproduction. 1994;9(SUPPL. 1):162-173.
  40

• 126.

  1993

  Y.E. Shi; J. Torri; L. Yieh; A. Wellstein; M.E. Lippman; R.B. Dickson

  Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells

  Cancer Research. 1993;53(6):1409-1415.
  86

• 127.

  1993

  M.D. Johnson; J.A. Torri; M.E. Lippman; R.B. Dickson

  The role of cathepsin D in the invasiveness of human breast cancer cells

  Cancer Research. 1993;53(4):873-877.
  86

• 128.

  1993

  R. Lupu; M.E. Lippman

  The role of erbB2 signal transduction pathways in human breast cancer

  Breast Cancer Research and Treatment. 1993;27(1-2):83-93.
  40

• 129.

  1993

  S. Swain; A. Wellstein; B. Parker; M. Lippman; C. Steakley; R. DeLap

  Heparin-binding growth factor blockade with pentosan polysulfate

  Annals of the New York Academy of Sciences. 1993;698:63-70.
  7

• 130.

  1993

  L.A. Hilakivi-Clarke; P.K. Arora; R. Clarke; A. Wright; M.E. Lippman; R.B. Dickson

  Opposing behavioural alterations in male and female transgenic TGFα mice: association with tumour susceptibility

  British Journal of Cancer. 1993;67(5):1026-1030.
  11

• 131.

  1993

  J. Kurebayashi; S.W. McLeskey; M.D. Johnson; M.E. Lippman; R.B. Dickson; F.G. Kern

  Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and lacZ

  Cancer Research. 1993;53(9):2178-2187.
  63

• 132.

  1993

  L. Hilakivi-Clarke; A. Wright; M.E. Lippman

  DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment

  Physiology and Behavior. 1993;54(2):229-236.
  24

• 133.

  1993

  S.W. McLeskey; J. Kurebayashi; S.F. Honig; J. Zwiebel; M.E. Lippman; R.B. Dickson; F.G. Kern

  Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice

  Cancer Research. 1993;53(9):2168-2177.
  94

• 134.

  1993

  T. Ojasoo; M.E. Lippman; H. Rochefort; M. Namer

  New drugs for breast cancer

  European Journal of Cancer Part A: General Topics. 1993;29(7):1068-1069+1071.
  0

• 135.

  1993

  R.B. Dickson; M.D. Johnson; D. El-Ashry; Y.E. Shi; M. Bano; G. Zugmaier; B. Ziff; M.E. Lippman; S. Chrysogelos

  Breast cancer: Influence of endocrine hormones, growth factors and genetic alterations

  Advances in Experimental Medicine and Biology. 1993;330:119-141.
  11

• 136.

  1993

  B.W. Parker; S.M. Swain; G. Zugmaier; R.L. DeLap; M.E. Lippman; A. Wellstein

  Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate

  Journal of the National Cancer Institute. 1993;85(13):1068-1073.
  18

• 137.

  1993

  N. Brunner; T.L. Frandsen; C. Holst-Hansen; M. Bei; E.W. Thompson; A.E. Wakeling; M.E. Lippman; R. Clarke

  MCF7/LCC2: A 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780

  Cancer Research. 1993;53(14):3229-3232.
  134

• 138.

  1993

  Y.E. Shi; J. Torri; L. Yieh; M.E. Sobel; Y. Yamada; M.E. Lippman; R.B. Dickson; E.W. Thompson

  Expression of 67 kDa laminin receptor in human breast cancer cells: Regulation by progestins

  Clinical and Experimental Metastasis. 1993;11(3):251-261.
  16

• 139.

  1993

  N. Brunner; V. Boulay; A. Fojo; C.E. Freter; M.E. Lippman; R. Clarke

  Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications

  Cancer Research. 1993;53(2):283-290.
  69

• 140.

  1993

  M.E. Lippman

  The development of biological therapies for breast cancer

  Science. 1993;259(5095):631-632.
  26

• 141.

  1993

  E.W. Thompson; N. Brunner; J. Torri; M.D. Johnson; V. Boulay; A. Wright; M.E. Lippman; P.S. Steeg; R. Clarke

  The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells

  Clinical and Experimental Metastasis. 1993;11(1):15-26.
  54

• 142.

  1993

  H.S. Azzam; G. Arand; M.E. Lippman; E.W. Thompson

  Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production

  Journal of the National Cancer Institute. 1993;85(21):1758-1764.
  165

• 143.

  1993

  N. Brunner; D. Yee; F.G. Kern; M. Spang-Thomsen; M.E. Lippman; K.J. Cullen

  Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)

  European Journal of Cancer Part A: General Topics. 1993;29(4):562-569.
  42

• 144.

  1993

  T. Ojasoo; M.E. Lippman; H. Rochefort; M. Namer

  Breast cancer: When tumor markers become targets for drugs

  Annals of Oncology. 1993;4(3):195-197.
  2

• 145.

  1992

  J.R. Harris; M.E. Lippman; U. Veronesi; W. Willett

  Medical progress: Breast cancer (First of three parts)

  New England Journal of Medicine. 1992;327(5):319-328.
  415

• 146.

  1992

  G. Zugmaier; M.E. Lippman; A. Wellstein

  Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals

  Journal of the National Cancer Institute. 1992;84(22):1716-1724.
  79

• 147.

  1992

  K. Straus; A. Lichter; M. Lippman; D. Danforth; S. Swain; K. Cowan; E. deMoss; H. MacDonald; S. Steinberg; et al.

  Results of the National Cancer Institute early breast cancer trial.

  Journal of the National Cancer Institute. Monographs. 1992;(11):27-32.
  39

• 148.

  1992

  Mozeena Bano; Ruth Lupu; William R. Kidwell; Marc E. Lippman; Robert B. Dickson

  Production and characterization of mammary-derived growth factor 1 in mammary epithelial cell lines

  Biochemistry. 1992;31(2):610-616.
  2

• 149.

  1992

  E.W. Thompson; S. Paik; N. Brunner; C.L. Sommers; G. Zugmaier; R. Clarke; T.B. Shima; J. Torri; S. Donahue; et al.

  Association of increased basement membrane invasiveness with abscence of estrogen receptor and expression of vimentin in human breast cancer cell lines

  Journal of Cellular Physiology. 1992;150(3):534-544.
  348

• 150.

  1992

  R. Clarke; R.B. Dickson; M.E. Lippman

  Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions

  Critical Reviews in Oncology/Hematology. 1992;12(1):1-23.
  80

• 151.

  1992

  R. Lupu; R. Colomer; B. Kannan; M.E. Lippman

  Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

  Proceedings of the National Academy of Sciences of the United States of America. 1992;89(6):2287-2291.
  54

• 152.

  1992

  K.J. Cullen; M.E. Lippman; D. Chow; S. Hill; N. Rosen; J.A. Zwiebel

  Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression

  Molecular Endocrinology. 1992;6(1):91-100.
  81

• 153.

  1992

  Lori Pierce; Kenneth Cowan; Eli Glatstein; Mart Lippman

  Response to "local control for locally advanced breast cancer: many opinions, few facts"

  International Journal of Radiation Oncology, Biology, Physics. 1992;23(5):1093.
  0

• 154.

  1992

  M. Bano; P. Worland; W.R. Kidwell; M.E. Lippman; R.B. Dickson

  Receptor-induced phosphorylation by mammary-derived growth factor 1 in mammary epithelial cell lines

  Journal of Biological Chemistry. 1992;267(15):10389-10392.
  4

• 155.

  1992

  R. Lupu; R.B. Dickson; M.E. Lippman

  The role of erbB-2 and its ligands in growth control of malignant breast epithelium

  Journal of Steroid Biochemistry and Molecular Biology. 1992;43(1-3):229-236.
  14

• 156.

  1992

  A.S. Lichter; M.E. Lippman; D.N. Danforth Jr.; T. D'Angelo; S.M. Steinberg; E. DeMoss; H.D. MacDonald; C.M. Reichert; M. Merino; S.M. Swain; et al.

  Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute

  Journal of Clinical Oncology. 1992;10(6):976-983.
  180

• 157.

  1992

  R.B. Dickson; M.E. Lippman

  Molecular determinants of growth, angiogenesis, and metastases in breast cancer

  Seminars in Oncology. 1992;19(3):286-298.
  28

• 158.

  1992

  Robert B. Dickson; Michael D. Johnson; Mozeena Bano; Eric Shi; Junichi Kurebayashi; Barbara Ziff; Isabel Martinez-Lacaci; Laufey T. Amundadottir; Marc E. Lippman

  Growth factors in breast cancer: Mitogenesis to transformation

  Journal of Steroid Biochemistry and Molecular Biology. 1992;43(1-3):69-78.
  29

• 159.

  1992

  L. Gerber; M. Lampert; C. Wood; M. Duncan; T. D'Angelo; W. Schain; H. McDonald; D. Danforth; P. Findlay; et al.

  Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation

  Breast Cancer Research and Treatment. 1992;21(2):139-145.
  75

• 160.

  1992

  Leena A. Hilakivi-Clarke; Prince K. Arora; Mary-Beth Sabol; Robert Clarke; Robert B. Dickson; Marc E. Lippman

  Alterations in behavior, steroid hormones and natural killer cell activity in male transgenic TGFα mice

  Brain Research. 1992;588(1):97-103.
  24

• 161.

  1992

  L.J. Pierce; M. Lippman; N. Ben-Baruch; S. Swain; J. O'Shaughnessy; J.L. Bader; D. Danforth; D. Venzon; K.H. Cowan

  The effect of systemic therapy on local-regional control in locally advanced breast cancer

  International Journal of Radiation Oncology Biology Physics. 1992;23(5):949-960.
  52

• 162.

  1992

  Anton Wellstein; Wenjing Fang; Ashok Khatri; Yang Lu; Sandra S. Swain; Robert B. Dickson; Joachim Sasse; Anna Tate Riegel; Marc E. Lippman

  A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine

  Journal of Biological Chemistry. 1992;267(4):2582-2587.
  64

• 163.

  1992

  S.S. Bacus; E. Huberman; D. Chin; K. Kiguchi; S. Simpson; M. Lippman; R. Lupu

  A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 1992;3(7):401-411.
  67

• 164.

  1992

  R.B. Dickson; D.S. Salomon; M.E. Lippman

  Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer.

  Cancer treatment and research. 1992;61:249-273.
  15

• 165.

  1992

  S. Paik; E. Burkhard; M.E. Lippman

  Clinical significance of erbB2 protein overexpression.

  Cancer treatment and research. 1992;61:181-191.
  7

• 166.

  1992

  K.J. Cullen; M.E. Lippman

  Stromal-epithelial interactions in breast cancer.

  Cancer treatment and research. 1992;61:413-431.
  12

• 167.

  1992

  J.R. Harris; M.E. Lippman; U. Veronesi; W. Willett

  Medical progress: Breast cancer (second of three parts)

  New England Journal of Medicine. 1992;327(6):390-398.
  92

• 168.

  1992

  W.L. Roper; S. Shapiro; B.A. Miller; E.J. Feuer; B.F. Hankey; J. Harris; M.E. Lippman; W. Willett

  Breast cancer [1]

  New England Journal of Medicine. 1992;327(24):1755-1757.
  0

• 169.

  1992

  J.R. Harris; M.E. Lippman; U. Veronesi; W. Willett

  Medical progress: Breast cancer (Third of three parts)

  New England Journal of Medicine. 1992;327(7):473-480.
  97

• 170.

  1992

  Marc E. Lippman

  Editor-in-chief's page

  Breast Cancer Research and Treatment. 1992;23(1-2):3.
  0

• 171.

  1991

  S.M. Levy; R.B. Herberman; M. Lippman; T. D'Angelo; J. Lee

  Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer

  Behavioral Medicine. 1991;17(2):67-75.
  104

• 172.

  1991

  D. Yee; R.E. Favoni; M.E. Lippman; D.R. Powell

  Identification of insulin-like growth factor binding proteins in breast cancer cells

  Breast Cancer Research and Treatment. 1991;18(1):3-10.
  36

• 173.

  1991

  M. Lippman

  An African Index Medicus [15]

  Lancet. 1991;338(8767):637.
  0

• 174.

  1991

  A. Wellstein; G. Zugmaier; J.A. Califano III; F. Kern; S. Paik; M.E. Lippman

  Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate

  Journal of the National Cancer Institute. 1991;83(10):716-720.
  55

• 175.

  1991

  T.R. Spitzer; S.M. Swain; M.E. Lippman; H.J. Deeg

  Reimbursement for solid tumor autologous bone marrow transplantation trials: A strategy for ensuring continuation of a promising therapy

  Cancer Investigation. 1991;9(1):93-97.
  2

• 176.

  1991

  R.B. Dickson; S. Paik; S. Chrysogelos; M.B. Martin; M.E. Lippman

  Molecular basis of steroid and growth factor receptors as prognostic variables in breast cancer

  Journal of Clinical Immunoassay. 1991;14(3):171-183.
  0

• 177.

  1991

  G. Zugmaier; S. Paik; G. Wilding; C. Knabbe; M. Bano; R. Lupu; B. Deschauer; S. Simpson; R.B. Dickson; M. Lippman

  Transforming growth factor β1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice

  Cancer Research. 1991;51(13):3590-3594.
  56

• 178.

  1991

  K.J. Cullen; M.E. Lippman

  Endocrine dependent tumors in man

  New Trends in Gynaecology and Obstetrics. 1991;7(3-4):187-197.
  0

• 179.

  1991

  Soonmyoung Paik; C. Richter King; Susan Simpson; Marc E. Lippman

  Quantification of erbB-2/neu levels in tissue

  Methods in Enzymology. 1991;198:290-300.
  9

• 180.

  1991

  B.W. Ennis; M.E. Lippman; R.B. Dickson

  The EGF receptor system as a target for antitumor therapy

  Cancer Investigation. 1991;9(5):553-562.
  90

• 181.

  1991

  M. Saceda; C. Knabbe; R.B. Dickson; M.E. Lippman; D. Bronzert; R.K. Lindsey; M.M. Gottardis; M.B. Martin

  Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-Tetradecanoylphorbol-13-acetate

  Journal of Biological Chemistry. 1991;266(27):17809-17814.
  50

• 182.

  1991

  G. Zugmaier; C. Knabbe; C. Fritsch; S. Simpson; B. Ennis; M. Lippman; R.B. Dickson

  Tissue culture conditions determine the effects of estrogen and growth factors on the anchorage independent growth of human breast cancer cell lines

  Journal of Steroid Biochemistry and Molecular Biology. 1991;39(5 A):681-685.
  9

• 183.

  1991

  Neal Rosen; Douglas Yee; Marc E. Lippman; Soonmyoung Paik; Kevin J. Cullen

  Insulin-like growth factors in human breast cancer

  Breast Cancer Research and Treatment. 1991;18(1 Supplement):S55-S62.
  38

• 184.

  1991

  E.W. Thompson; M.E. Lippman; R.B. Dickson

  At the cutting edge. Regulation of basement membrane invasiveness in human breast cancer model systems

  Molecular and Cellular Endocrinology. 1991;82(1):C203+c204+c205+c206+c207+c208+.
  5

• 185.

  1991

  K. Stromberg; M. Duffy; C. Fritsch; W.R. Hudgins; E.S. Sharp; L.D. Murphy; M.E. Lippman; S.E. Bates

  Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.

  Cancer Detection and Prevention. 1991;15(4):277-283.
  5

• 186.

  1991

  C. Knabbe; G. Zugmaier; M. Schmahl; M. Dietel; M.E. Lippman; R.B. Dickson

  Induction of transforming growth factor β by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1991;14(SUPPL. 2):S15-S20.
  34

• 187.

  1991

  R. Lupu; R.B. Dickson; M.E. Lippman

  The role of erbB-2 and its ligands in growth control of malignant breast epithelium.

  Princess Takamatsu symposia. 1991;22:49-60.
  1

• 188.

  1991

  Kevin J. Cullen; Helene S. Smith; Suzanne Hill; Neal Rosen; Marc E. Lippman

  Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions

  Cancer Research. 1991;51(18):4978-4985.
  102

• 189.

  1990

  R. Clarke; M.E. Lippman; R.B. Dickson

  Mechanisms of hormone and cytotoxic drug interactions in the development and treatment of breast cancer.

  Progress in clinical and biological research. 1990;322:243-278.
  3

• 190.

  1990

  G. Zugmaier; M.E. Lippman

  Effects of TGFβ on normal and malignant mammary epithelium

  Annals of the New York Academy of Sciences. 1990;593:272-275.
  8

• 191.

  1990

  E.W. Thompson; T.B. Shima; G.R. Martin; G. Zugmaier; M.E. Lippman; R.B. Dickson

  TGFβ independently regulates invasiveness, chemotaxis, and proliferation of human breast cancer cells

  Annals of the New York Academy of Sciences. 1990;593:363-366.
  0

• 192.

  1990

  S.E. Bates; E.M. Valverius; B.W. Ennis; D.A. Bronzert; J.P. Sheridan; M.R. Stampfer; J. Mendelsohn; M.E. Lippman; R.B. Dickson

  Expression of the transforming growth factor-α/epidermal growth factor receptor pathway in normal human breast epithelial cells

  Endocrinology. 1990;126(1):596-607.
  42

• 193.

  1990

  M. Bano; W.R. Kidwell; M.E. Lippman; R.B. Dickson

  Characterization of mammary-derived growth factor 1 receptors and response in human mammary epithelial cell lines

  Journal of Biological Chemistry. 1990;265(4):1874-1880.
  3

• 194.

  1990

  Ruth Lupu; Ramon Colomer; Gerhard Zugmaier; Jay Sarup; Michael Shepard; Dennis Slamon; Marc E. Lippman

  Direct interaction of a ligand for the erbE2 oncogene product with the EGF receptor and p185^erbB2

  Science. 1990;249(4976):1552-1555.
  65

• 195.

  1990

  D.A. Bronzert; S.E. Bates; J.P. Sheridan; R. Lindsey; E.M. Valverius; M.R. Stampfer; M.E. Lippman; R.B. Dickson

  Transforming growth factor-β induces platelet-derived growth factor (PDGF) messenger RNA and PDGF secretion while inhibiting growth in normal human mammary epithelial cells

  Molecular Endocrinology. 1990;4(7):981-989.
  11

• 196.

  1990

  K.J. Cullen; D. Yee; W.S. Sly; J. Perdue; B. Hampton; M.E. Lippman; N. Rosen

  Insulin-like growth factor receptor expression and function in human breast cancer

  Cancer Research. 1990;50(1):48-53.
  174

• 197.

  1990

  O. Kaplan; J.W. Jaroszewski; P.J. Faustino; G. Zugmaier; B.W. Ennis; M. Lippman; J.S. Cohen

  Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells

  Journal of Biological Chemistry. 1990;265(23):13641-13649.
  14

• 198.

  1990

  Soonmyoung Paik; Rachel Hazan; Edwin R. Fisher; Richard E. Sass; Bernard Fisher; Carol Redmond; Joseph Schlessinger; Marc E. Lippman; C. Richter King

  Pathologic findings from the national surgical adjuvant breast and bowel project: Prognostic significance of erbE-2 protein overexpression in primary breast cancer

  Journal of Clinical Oncology. 1990;8(1):103-112.
  321

• 199.

  1990

  E.M. Valverius; F. Ciardiello; N.-E. Heldin; B. Blondel; G. Merlo; G. Smith; M.R. Stampfer; M.E. Lippman; R.B. Dickson; D.S. Salomon

  Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T

  Journal of Cellular Physiology. 1990;145(2):207-216.
  24

• 200.

  1990

  S. Kennedy; M.J. Merino; S.M. Swain; M.E. Lippman

  The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue

  Human Pathology. 1990;21(2):192-198.
  54

• 201.

  1990

  M. Lippman; E. Mihich

  Second Annual Pezcoller Symposium: Therapeutic implications of the molecular biology of breast cancer

  Cancer Research. 1990;50(22):7402-7404.
  0

• 202.

  1990

  D.N. Danforth Jr.; M.E. Lippman; H. McDonald; J. Bader; E. Egan; M. Lampert; S.M. Steinberg; S.M. Swain

  Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer

  American Surgeon. 1990;56(1):6-11.
  25

• 203.

  1990

  M.E. Lippman; D. Yee

  The lymphomas: current concepts in pathogenesis and management. Introduction

  NCI Monographs. 1990;(10):1.
  0

• 204.

  1990

  H.S. Smith; W. Zoli; A. Volpi; A. Hiller; M. Lippman; S. Swain; B. Mayall; C. Dollbaum; A.J. Hackett; et al.

  Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells

  Cancer Research. 1990;50(10):2943-2948.
  17

• 205.

  1990

  A. Wellstein; R. Lupu; G. Zugmaier; S.L. Flamm; A.L. Cheville; P. Delli Bovi; C. Basilico; M.E. Lippman; F.G. Kern

  Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.

  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research. 1990;1(2):63-71.
  30

• 206.

  1990

  L.C. Chiedozi; K.K. Huff; M.E. Wesley; M.E. Lippman

  Progesterone receptors in advanced breast cancer.

  West African Journal of Medicine. 1990;9(3):208-213.
  0

• 207.

  1990

  J. Ragaz; L. Simpson-Herren; M. Lippman; B. Fisher

  Questions related to the effects of therapy on biology and kinetics of the surviving tumor.

  Progress in clinical and biological research. 1990;354 A:1-6.
  0

• 208.

  1990

  M.E. Lippman; R.B. Dickson

  Growth control of normal and malignant breast epithelium.

  Progress in clinical and biological research. 1990;354 A:147-178.
  13

• 209.

  1990

  R.B. Dickson; E.W. Thompson; M.E. Lippman

  Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids

  Journal of Steroid Biochemistry and Molecular Biology. 1990;37(3):305-316.
  50

• 210.

  1990

  R.B. Dickson; M.E. Lippman; D. Slamon

  New insights into breast cancer: The molecular biochemical and cellular biology of breast cancer

  Cancer Research. 1990;50(14):4446-4447.
  2

• 211.

  1990

  Marc E. Lippman; Robert B. Dickson

  Mechanisms of growth control in normal and malignant breast epithelium

  Recent Progress in Hormone Research. 1990;45(1):383-435.
  64

• 212.

  1989

  S.M. Swain; M.E. Lippman

  Systemic therapy of locally advanced breast cancer: Review and guidelines

  ONCOLOGY. 1989;3(1):21-28.
  3

• 213.

  1989

  M. Saceda; M.E. Lippman; R.K. Lindsey; M. Puente; M.B. Martin

  Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells

  Molecular Endocrinology. 1989;3(11):1782-1787.
  52

• 214.

  1989

  C.R. King; S.M. Swain; L. Porter; S.M. Steinberg; M.E. Lippman; E.P. Gelmann

  Heterogeneous expression of erbB-2 messenger RNA in human breast cancer

  Cancer Research. 1989;49(15):4185-4191.
  20

• 215.

  1989

  S. Swain; R. Dickson; M. Lippman

  Growth factor secretion in human breast carcinoma

  Archives of Gynecology and Obstetrics. 1989;245(1-4):669-670.
  0

• 216.

  1989

  S.M. Swain; M.E. Lippman; E.F. Egan; J.C. Drake; S.M. Steinberg; C.J. Allegra

  Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer

  Journal of Clinical Oncology. 1989;7(7):890-899.
  143

• 217.

  1989

  G. Zugmaier; B.W. Ennis; B. Deschauer; D. Katz; C. Knabbe; G. Wilding; P. Daly; M.E. Lippman; R.B. Dickson

  Transforming growth factors type β1 and β2 are equipotent growth inhibitors of human breast cancer cell lines

  Journal of Cellular Physiology. 1989;141(2):353-361.
  71

• 218.

  1989

  D. Yee; R.E. Favoni; R. Lupu; K.J. Cullen; G.S. Lebovic; K.K. Huff; P.D.K. Lee; Y.L. Lee; D.R. Powell; et al.

  The insulin-like growth factor binding protein BP-25 is expressed by human breast cancer cells

  Biochemical and Biophysical Research Communications. 1989;158(1):38-44.
  5

• 219.

  1989

  P.J. Worland; D. Bronzert; R.B. Dickson; M.E. Lippman; L. Hampton; S.S. Thorgeirsson; P.J. Wirth

  Secreted and cellular polypeptide patterns of MCF-7 human breast cancer cells following either estrogen stimulation or v-H-ras transfection

  Cancer Research. 1989;49(1):51-57.
  12

• 220.

  1989

  R. Clarke; N. Brunner; D. Katz; P. Glanz; R.B. Dickson; M.E. Lippman; F.G. Kern

  The effects of a constitutive expression of transforming growth factor-α on the growth of MCF-7 human breast cancer cells in vitro and in vivo

  Molecular Endocrinology. 1989;3(2):372-380.
  42

• 221.

  1989

  N. Brunner; D. Bronzert; L.L. Vindelov; K. Rygaard; M. Spang-Thomsen; M.E. Lippman

  Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice

  Cancer Research. 1989;49(6):1515-1520.
  45

• 222.

  1989

  D. Yee; S. Paik; G.S. Lebovic; R.R. Marcus; R.E. Favoni; K.J. Cullen; M.E. Lippman; N. Rosen

  Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer

  Molecular Endocrinology. 1989;3(3):509-517.
  190

• 223.

  1989

  E.M. Valverius; S.E. Bates; M.R. Stampfer; R. Clark; F. McCormick; D.S. Salomon; M.E. Lippman; R.B. Dickson

  Transforming growth factor α production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells

  Molecular Endocrinology. 1989;3(1):203-214.
  36

• 224.

  1989

  S.M. Swain; M.E. Lippman

  Treatment of patients with inflammatory breast cancer.

  Important advances in oncology. 1989:129-150.
  20

• 225.

  1989

  S.M. Levy; R.B. Herberman; J.K. Lee; M.E. Lippman; T. d'Angelo

  Breast conservation versus mastectomy: Distress sequelae as a function of choice

  Journal of Clinical Oncology. 1989;7(3):367-375.
  62

• 226.

  1989

  R.B. Dickson; E.W. Thompson; M.E. Lippman

  Hormones and breast cancer in vitro.

  Human cell : official journal of Human Cell Research Society. 1989;2(3):219-230.
  6

• 227.

  1989

  E.W. Thompson; M.B. Martin; M. Saceda; R. Clarke; N. Brunner; M.E. Lippman; R.B. Dickson

  Regulation of breast cancer cells by hormones and growth factors: Effects on proliferation and basement membrane invasiveness

  Hormone Research. 1989;32(SUPPL. 1):242-249.
  6

• 228.

  1989

  M. Lippman

  Growth regulation of breast cancer.

  Progress in clinical and biological research. 1989;320:111-119.
  4

• 229.

  1989

  Kevin J. Cullen; Marc E. Lippman

  Estrogen Regulation of Protein Synthesis and Cell Growth in Human Breast Cancer

  Vitamins and Hormones. 1989;45(C):127-172.
  12

• 230.

  1989

  M.E. Lippman; R.B. Dickson

  Mechanisms of normal and malignant breast epithelial growth regulation

  Journal of Steroid Biochemistry. 1989;34(1-6):107-121.
  24

• 231.

  1989

  K.J. Cullen; D. Yee; S.E. Bates; N. Brunner; R. Clarke; R.E. Dickson; K.K. Huff; S. Paik; N. Rosen; E. Valverius; et al.

  Regulation of human breast cancer by secreted growth factors

  Acta Oncologica. 1989;28(6):835-840.
  11

• 232.

  1989

  E.W. Thompson; D. Katz; T.B. Shima; A.E. Wakeling; M.E. Lippman; R.B. Dickson

  ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness

  Cancer Research. 1989;49(24 I):6929-6934.
  45

• 233.

  1989

  E.M. Valverius; D. Walker-Jones; S.E. Bates; M.R. Stampfer; R. Clark; F. McCormick; R.B. Dickson; M.E. Lippman

  Production of and responsiveness to transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells

  Cancer Research. 1989;49(22):6269-6274.
  52

• 234.

  1989

  M.E. Lippman

  Can oncologists add?

  Journal of Clinical Oncology. 1989;7(6):698-699.
  0

• 235.

  1989

  R. Clarke; N. Brunner; E.W. Thompson; P. Glanz; D. Katz; R.B. Dickson; M.E. Lippman

  The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer

  Journal of Endocrinology. 1989;122(1):331-340.
  35

• 236.

  1989

  D.S. Salomon; W.R. Kidwell; N. Kim; F. Ciardiello; S.E. Bates; E. Valverius; M.E. Lippman; R.B. Dickson; M. Stampfer

  Modulation by estrogen and growth factors of transforming growth factor-alpha and epidermal growth factor receptor expression in normal and malignant human mammary epithelial cells.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1989;113:57-69.
  8

• 237.

  1989

  S. Paik; N. Rosen; W. Jung; J.M. You; M.E. Lippman; J.F. Perdue; D. Yee

  Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study

  Laboratory Investigation. 1989;61(5):522-526.
  7

• 238.

  1989

  F. Ciardiello; N. Hynes; N. Kim; E.M. Valverius; M.E. Lippman; D.S. Salomon

  Transformation of mouse mammary epithelial cells with the Ha-ras but not with the neu oncogene results in a gene dosage-dependent increase in transforming growth factor-α production

  FEBS Letters. 1989;250(2):474-478.
  3

• 239.

  1989

  B.W. Ennis; E.M. Valverius; S.E. Bates; M.E. Lippman; F. Bellot; R. Kris; J. Schlessinger; H. Masui; A. Goldenberg; et al.

  Anti-epidermal growth factor receptor antibodies inhibited the autocrine-stimulated growth of MDA-468 human breast cancer cells

  Molecular Endocrinology. 1989;3(11):1830-1838.
  71

• 240.

  1989

  D. Walker-Jones; E.M. Valverius; M.R. Stampfer; M.E. Lippman; R.B. Dickson

  Stimulation of epithelial membrane antigen expression by transforming growth factor-β in normal and oncogene-transformed human mammary epithelial cells

  Cancer Research. 1989;49(22):6407-6411.
  3

• 241.

  1989

  V. Shankar; F. Ciardiello; N. Kim; R. Derynck; D.S. Liscia; G. Merlo; B.C. Langton; D. Sheer; R. Callahan; et al.

  Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA

  Molecular Carcinogenesis. 1989;2(1):1-11.
  23

• 242.

  1989

  R. Clarke; N. Brunner; B.S. Katzenellenbogen; E.W. Thompson; M.J. Norman; C. Koppi; S. Paik; M.E. Lippman; R.B. Dickson

  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo

  Proceedings of the National Academy of Sciences of the United States of America. 1989;86(10):3649-3653.
  81

• 243.

  1989

  N.E. Davidson; M.E. Lippman

  The role of estrogens in growth regulation of breast cancer.

  Critical reviews in oncogenesis. 1989;1(1):89-111.
  41

• 244.

  1989

  M.E. Lippman; R.B. Dickson

  Mitogenic regulation of normal and malignant breast epithelium

  Yale Journal of Biology and Medicine. 1989;62(5):459-480.
  7

• 245.

  1989

  N. Brunner; G. Zugmaier; M. Bano; B.W. Ennis; R. Clarke; K.J. Cullen; F.G. Kern; R.B. Dickson; M.E. Lippman

  Endocrine therapy of human breast cancer cells: The role of secreted polypeptide growth factors

  Cancer Cells. 1989;1(3):81-86.
  10

• 246.

  1988

  S.M. Swain; S.M. Steinberg; C. Bagley; M.E. Lippman

  Tamoxifen and fluoxymesterone versus tamoxifen and danazol in metastatic breast cancer. A randomized study

  Breast Cancer Research and Treatment. 1988;12(1):51-57.
  1

• 247.

  1988

  M.E. Lippman

  Oncogenes and breast cancer

  New England Journal of Medicine. 1988;319(19):1281-1282.
  0

• 248.

  1988

  M.E. Lippman; R.B. Dickson; E.P. Gelmann; N. Rosen; C. Knabbe; S. Bates; D. Bronzert; K. Huff; A. Kasid

  Growth regulatory peptide production by human breast carcinoma cells

  Journal of Steroid Biochemistry. 1988;30(1-6):53-61.
  21

• 249.

  1988

  G. Wilding; M.E. Lippman; R.B. Dickson

  The cellular response of human breast cancer to estrogen.

  Progress in clinical and biological research. 1988;262:181-196.
  2

• 250.

  1988

  S.M. Swain; S. Steinberg; M. Lippman

  Salvage treatment with intermediate-dose methotrexate and 5-fluorouracil in metastatic breast cancer

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1988;11(4):445-447.
  0

• 251.

  1988

  S.M. Levy; J. Lee; C. Bagley; M. Lippman

  Survival hazards analysis in first recurrent breast cancer patients: Seven-year follow-up

  Psychosomatic Medicine. 1988;50(5):520-528.
  33

• 252.

  1988

  C.E. Freter; M.E. Lippman; A. Cheville; S. Zinn; E.P. Gelmann

  Alterations in phosphoinositide metabolism associated with 17β-estradiol and growth factor treatment of MCF-7 breast cancer cells

  Molecular Endocrinology. 1988;2(2):159-166.
  21

• 253.

  1988

  G. Wilding; M.E. Lippman; E.P. Gelmann

  Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells

  Cancer Research. 1988;48(4):802-805.
  33

• 254.

  1988

  K.K. Huff; C. Knabbe; R. Lindsey; D. Kaufman; D. Bronzert; M.E. Lippman; R.B. Dickson

  Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells

  Molecular Endocrinology. 1988;2(3):200-208.
  32

• 255.

  1988

  A. Thor; M.J. Viglione; N. Ohuchi; J. Simpson; R. Steis; J. Cousar; M. Lippman; D.W. Kufe; J. Schlom

  Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow

  Breast Cancer Research and Treatment. 1988;11(2):133-145.
  26

• 256.

  1988

  S.E. Bates; N.E. Davidson; E.M. Valverius; C.E. Freter; R.B. Dickson; J.P. Tam; J.E. Kudlow; M.E. Lippman; D.S. Salomon

  Expression of transforming growth factor α and its messenger ribonucleic acid in human breast cancer: Its regulation by estrogen and its possible functional significance

  Molecular Endocrinology. 1988;2(6):543-555.
  155

• 257.

  1988

  R.B. Dickson; M.E. Lippman

  Control of human breast cancer by estrogen, growth factors, and oncogenes.

  Cancer treatment and research. 1988;40:119-165.
  26

• 258.

  1988

  E.W. Thompson; R. Reich; T.B. Shima; A. Albini; J. Graf; G.R. Martin; R.B. Dickson; M.E. Lippman

  Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens

  Cancer Research. 1988;48(23):6764-6768.
  72

• 259.

  1988

  D. Yee; K.J. Cullen; S. Paik; J.F. Perdue; B. Hampton; A. Schwartz; M.E. Lippman; N. Rosen

  Insulin-like growth factor II mRNA expression in human breast cancer

  Cancer Research. 1988;48(23):6691-6696.
  110

• 260.

  1988

  M. Saceda; M.E. Lippman; P. Chambon; R.L. Lindsey; M. Ponglikitmongkol; M. Puente; M.B. Martin

  Regulation of the estrogen receptor in MCF-7 cells by estradiol

  Molecular Endocrinology. 1988;2(12):1157-1162.
  170

• 261.

  1987

  S.M. Swain; M.E. Lippman

  Controversies in the treatment of cancer of the breast.

  Annual Review of Medicine. 1987;38:287-294.
  0

• 262.

  1987

  W.L. McGuire; M.E. Lippman; C.K. Osborne; E.B. Thompson

  Resistance to endocrine therapy. A panel discussion.

  Breast Cancer Research and Treatment. 1987;9(3):165-173.
  0

• 263.

  1987

  Marc E. Lippman; Susan Bates; Karen K. Huff; Nancy Davidson; Robert B. Dickson

  Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer

  The Journal of Laboratory and Clinical Medicine. 1987;109(3):230-235.
  3

• 264.

  1987

  M.E. Lippman

  Hormone stimulation and chemotherapy for breast cancer

  Journal of Clinical Oncology. 1987;5(3):331-332.
  0

• 265.

  1987

  S. Levy; R. Herberman; M. Lippman; T. D'Angelo

  Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer

  Journal of Clinical Oncology. 1987;5(3):348-353.
  114

• 266.

  1987

  C.S. Bagley; M.N. Wesley; R.C. Young; M.E. Lippman

  Adjuvant chemotherapy in males with cancer of the breast

  American Journal of Clinical Oncology: Cancer Clinical Trials. 1987;10(1):55-60.
  74

• 267.

  1987

  D. Bronzert; S. Silverman; M. Lippmann

  Estrogen inhibition of a M(r) 39,000 glycoprotein secreted by human breast cancer cells

  Cancer Research. 1987;47(5):1234-1238.
  1

• 268.

  1987

  N.E. Davidson; M.E. Lippman

  Stimulation of breast cancer with estrogens: How much clinical value?

  European Journal of Cancer and Clinical Oncology. 1987;23(7):897-900.
  1

• 269.

  1987

  S.M. Swain; R.A. Sorace; C.S. Bagley; D.N. Danforth Jr.; J. Bader; M.N. Wesley; S.M. Steinberg; M.E. Lippman

  Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer

  Cancer Research. 1987;47(14):3889-3894.
  139

• 270.

  1987

  H.S. Smith; S.R. Wolman; S.H. Dairkee; M.C. Hancock; M. Lippman; A. Leff; A.J. Hackett

  Immortalization in culture: Occurrence at a late stage in the progression of breast cancer

  Journal of the National Cancer Institute. 1987;78(4):611-615.
  19

• 271.

  1987

  R.B. Dickson; M.E. Lippman

  Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma.

  Endocrine Reviews. 1987;8(1):29-43.
  200

• 272.

  1987

  N.E. Davidson; E.P. Gelmann; M.E. Lippman; R.B. Dickson

  Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

  Molecular endocrinology (Baltimore, Md.). 1987;1(3):216-223.
  116

• 273.

  1987

  M.E. Lippman

  Women and breast cancer.

  Public Health Reports. 1987;Suppl:97-99.
  0

• 274.

  1987

  Attan Kasid; Marc E. Lippman

  Estrogen and oncogene mediated growth regulation of human breast cancer cells

  Journal of Steroid Biochemistry. 1987;27(1-3):465-470.
  22

• 275.

  1987

  Robert B. Dickson; Susan Aitken; Marl E. Lippman

  [31] Assay of Mitogen-Induced Effects on Cellular Incorporation of Precursors for Scavenger, de Novo, and Net DNA Synthesis

  Methods in Enzymology. 1987;146(C):329-340.
  1

• 276.

  1987

  C.J. Allegra; B.A. Chabner; P.W. Sholar; C. Bagley; J.C. Drake; M.E. Lippman

  Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin

  NCI Monographs. 1987;(5):199-202.
  2

• 277.

  1987

  A. Kasid; C. Knabbe; M.E. Lippman

  Effect of v-ras(H) oncogene transfection on estrogen-independent tumorigenicity of estrogen-dependent human breast cancer cells

  Cancer Research. 1987;47(21):5733-5738.
  8

• 278.

  1987

  M.E. Lippman; R.B. Dickson; E.P. Gelmann; N. Rosen; C. Knabbe; S. Bates; D. Bronzert; K. Huff; A. Kasid

  Growth regulation of human breast carcinoma occurs through regulated growth factor secretion

  Journal of Cellular Biochemistry. 1987;35(1):1-16.
  40

• 279.

  1987

  C. Knabbe; M.E. Lippman; L.M. Wakefield; K.C. Flanders; A. Kasid; R. Derynck; R.B. Dickson

  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells

  Cell. 1987;48(3):417-428.
  325

• 280.

  1987

  M.E. Lippman

  Selecting initial therapy for invasive breast cancer

  Cancer. 1987;60(8 SUPPl.):2050-2053.
  3

• 281.

  1987

  M.E. Lippman

  Women' health: Cancer. Women and breast cancer

  Public Health Reports. 1987;102(4 SUPPL. JULY/AUG.):97-99.
  0

• 282.

  1987

  R.B. Dickson; A. Kasid; K.K. Huff; S.E. Bates; C. Knabbe; D. Bronzert; E.P. Gelmann; M.E. Lippman

  Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β-estradiol or v-Ha-ras oncogene

  Proceedings of the National Academy of Sciences of the United States of America. 1987;84(3):837-841.
  62

• 283.

  1987

  D.A. Bronzert; P. Pantazis; H.N. Antoniades; A. Kasid; N. Davidson; R.B. Dickson; M.E. Lippman

  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines

  Proceedings of the National Academy of Sciences of the United States of America. 1987;84(16):5763-5767.
  68

• 284.

  1987

  Robert B. Dickson; Neil Rosen; Edward P. Gelmann; Marc E. Lippman

  Receptor- and signal transductionrelated proto-oncogenes in breast cancer

  Trends in Pharmacological Sciences. 1987;8(10):372-375.
  1

• 285.

  1986

  M.E. Lippman

  Management of breast cancer with hormones and drugs

  Hospital Practice. 1986;21(5):119-131.
  0

• 286.

  1986

  R.B. Dickson; M.E. McManaway; M.E. Lippman

  Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth

  Science. 1986;232(4757):1540-1543.
  61

• 287.

  1986

  M.E. Lippman; B.A. Chabner

  National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview.

  NCI monographs : a publication of the National Cancer Institute. 1986;(1):5-10.
  1

• 288.

  1986

  V.T. DeVita; M. Lippman; S.M. Hubbard; D.C. Ihde; S.A. Rosenberg

  The effect of combined modality therapy on local control and survival

  International Journal of Radiation Oncology, Biology, Physics. 1986;12(4):487-501.
  8

• 289.

  1986

  K.K. Huff; D. Kaufman; K.H. Gabbay; E.M. Spencer; M.E. Lippman; R.B. Dickson

  Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells

  Cancer Research. 1986;46(9):4613-4619.
  71

• 290.

  1986

  D.A. Bronzert; N. Davidson; M. Lippman

  Estrogen and antiestrogen resistance in human breast cancer cell lines.

  Advances in experimental medicine and biology. 1986;196:329-345.
  1

• 291.

  1986

  Marc E. Lippman; Robert B. Dickson; Attan Kasid; Edward Gelmann; Nancy Davidson; Mary McManaway; Karen Huff; Diane Bronzert; Susan Bates; Sandra Swain; et al.

  Autocrine and paracrine growth regulation of human breast cancer

  Journal of Steroid Biochemistry. 1986;24(1):147-154.
  33

• 292.

  1986

  M.E. McManaway; E.M. Jagoda; W.C. Eckelman; S.M. Larson; B.E. Francis; R.E. Gibson; R.C. Reba; M.E. Lippman

  Binding characteristics and biological activity of 17α-[¹²⁵I]iodovinyl-11β-methoxyestradiol, an estrogen receptor-binding radiopharmaceutical, in human breast cancer cells (MCF-7)

  Cancer Research. 1986;46(5):2386-2389.
  5

• 293.

  1986

  R.B. Dickson; S.E. Bates; M.E. McManaway; M.E. Lippman

  Characterization of estrogen responsive transforming activity in human breast cancer cell lines

  Cancer Research. 1986;46(4):1707-1713.
  54

• 294.

  1986

  R.B. Dickson; K.K. Huff; E.M. Spencer; M.E. Lippman

  Induction of epidermal growth factor-related polypeptides by 17β-estradiol in MCF-7 human breast cancer cells

  Endocrinology. 1986;118(1):138-142.
  49

• 295.

  1986

  D.N. Danforth Jr.; P.A. Findlay; H.D. McDonald; M.E. Lippman; C.M. Reichert; T. d'Angelo; C.R. Gorrell; N.L. Gerber; A.S. Lichter; S.A. Rosenberg

  Complete axillary lymph node dissection for stage I-II carcinoma of the breast

  Journal of Clinical Oncology. 1986;4(5):655-662.
  87

• 296.

  1986

  N.E. Davidson; D.A. Bronzert; P. Chambon; E.P. Gelmann; M.E. Lippman

  Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products

  Cancer Research. 1986;46(4 II):1904-1908.
  13

• 297.

  1986

  M.E. Lippman; R.B. Dickson; S. Bates

  Autocrine and paracrine growth regulation of human breast cancer

  Breast Cancer Research and Treatment. 1986;7(2):59-70.
  61

• 298.

  1986

  M. Lippman

  Analgesic potencies of dezocine and butorphanol.

  Anesthesia and analgesia. 1986;65(11):1246.
  0

• 299.

  1986

  R.B. Dickson; M.E. Lippman

  Hormonal control of human breast cancer cell lines.

  Cancer Surveys. 1986;5(3):617-624.
  7

• 300.

  1986

  R.B. Dickson; M.E. Lippman

  Role of estrogens in the malignant progression of breast cancer: New perspectives

  Trends in Pharmacological Sciences. 1986;7(8):294-296.
  0

• 301.

  1986

  M.E. Lippman; K.K. Huff; R. Jakesz; T. Hecht; A. Kasid; S. Bates; R.B. Dickson

  Estrogens regulate production of specific growth factors in hormone-dependent human breast cancer.

  Annals of the New York Academy of Sciences. 1986;464:11-16.
  6

• 302.

  1986

  M.E. Lippman; B.K. Edwards; P. Findlay; D.W. Danforth Jr.; H. MacDonald; T. D'Angelo; C. Gorrell

  Influence of definitive radiation therapy for primary breast cancer on ability to deliver adjuvant chemotherapy

  NCI Monographs. 1986;No. 1:99-104.
  2

• 303.

  1986

  A. Kasid; N.E. Davidson; E.P. Gelmann; M.E. Lippman

  Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells

  Journal of Biological Chemistry. 1986;261(12):5562-5567.
  12

• 304.

  1986

  M.E. Lippman; B.A. Chabner

  Editorial overview

  NCI Monographs. 1986;No. 1:5-10.
  1

• 305.

  1986

  A. Albini; J. Graf; G.T. Kitten; H.K. Kleinman; G.R. Martin; A. Veillette; M.E. Lippman

  17β-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane

  Proceedings of the National Academy of Sciences of the United States of America. 1986;83(21):8182-8186.
  41

• 306.

  1986

  M.E. Lippman; R.A. Sorace; C.S. Bagley; D.W. Danforth Jr.; A. Lichter; M.N. Wesley

  Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery

  NCI Monographs. 1986;No. 1:153-159.
  33

• 307.

  1985

  L.M. Weisenthal; M.E. Lippman

  Clonogenic and nonclonogenic in vitro chemosensitivity assays

  Cancer Treatment Reports. 1985;69(6):615-632.
  58

• 308.

  1985

  R.M. Levine; E. Rubalcaba; M.E. Lippman; K.H. Cowan

  Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line

  Cancer Research. 1985;45(4):1644-1650.
  7

• 309.

  1985

  D.N. Danforth Jr.; L. Tamarkin; J.J. Mulvihill; C.S. Bagley; M.E. Lippman

  Plasma melatonin and the hormone-dependency of human breast cancer

  Journal of Clinical Oncology. 1985;3(7):941-948.
  19

• 310.

  1985

  S.E. Bates; M.E. Lippman; R.B. Dickson

  Production of transforming growth factors (TGF) by human breast cancer (BC) cell lines

  Proceedings of the American Association for Cancer Research. 1985;VOL. 26:No. 778.
  0

• 311.

  1985

  S.C. Aitken; M.E. Lippman; A. Kasid; D.R. Schoenberg

  Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells

  Cancer Research. 1985;45(6):2608-2615.
  9

• 312.

  1985

  S.C. Aitken; M.E. Lippman

  Effects of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture

  Cancer Research. 1985;45(4):1611-1620.
  22

• 313.

  1985

  A. Kasid; M.E. Lippman; A.G. Papageorge

  Transfection of v-ras(h) DNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity

  Science. 1985;228(4700):725-728.
  37

• 314.

  1985

  S. Scholl; M.E. Lippman

  Estrogen receptor separation employing sucrose deuterium oxide gradients generated during sample centrifugation

  Breast Cancer Research and Treatment. 1985;5(1):47-50.
  0

• 315.

  1985

  E. Shapiro; M.E. Lippman

  Onset of androgen action in MCF-7 human breast cancer cells is not accompanied by receptor depletion

  Journal of Steroid Biochemistry. 1985;22(1):15-20.
  1

• 316.

  1985

  D.A. Bronzert; G.L. Greene; M.E. Lippman

  Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018

  Endocrinology. 1985;117(4):1409-1417.
  28

• 317.

  1985

  B.J. Brooks Jr.; M.E. Lippman

  Tamoxifen flare in advanced endometrial carcinoma

  Journal of Clinical Oncology. 1985;3(2):222-223.
  1

• 318.

  1985

  S.M. Levy; R.B. Herberman; A.M. Maluish; B. Schlien; M. Lippman

  Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters.

  Health Psychology. 1985;4(2):99-113.
  91

• 319.

  1985

  L.C. Chiedozi; M.E. Lippman

  Management of advanced breast cancer in Africa: Strategies in the absence of hormone receptor assay data

  International Surgery. 1985;70(1):57-61.
  2

• 320.

  1985

  L. Chiedozi; K.K. Huff; M. Wesley; M.E. Lippman

  Oestrogen receptors in advanced primary breast cancer

  East African Medical Journal. 1985;62(1):26-31.
  0

• 321.

  1985

  H.S. Smith; M.E. Lippman; A.J. Hiller; M.R. Stampfer; A.J. Hackett

  Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells

  Journal of the National Cancer Institute. 1985;74(2):341-347.
  6

• 322.

  1985

  G.W. Geelhoed; C. Alford; M.E. Lippman

  Biologic implications of steroid hormone receptors in cancers of the colon

  Southern Medical Journal. 1985;78(3):252-254.
  4

• 323.

  1985

  Timothy Eberlein; Richard Simon; Susan Fisher; Marc E. Lippman

  Height, weight, and risk of breast cancer relapse

  Breast Cancer Research and Treatment. 1985;5(1):81-86.
  16

• 324.

  1985

  S.K. Tsai; T.Y. Lee; M.S. Mok; M. Lippman

  Subarachnoid administration of butorphanol for the relief of postoperative pain.

  Acta Anaesthesiologica Sinica. 1985;23(3):121-123.
  1

• 325.

  1985

  M.E. Lippman

  Adjuvant systemic therapy of breast cancer.

  Important advances in oncology. 1985:254-272.
  0

• 326.

  1985

  M.E. Lippman; J. Cassidy; M. Wesley; R.C. Young

  Increasing the response rate to cytotoxic chemotherapy by endocrine means

  Journal of Steroid Biochemistry. 1985;23(6 B):1173-1180.
  4

• 327.

  1985

  Richard A. Sorace; Caroline S. Bagley; Allen S. Lichter; David N. Danforth Jr.; Margaret W. Wesley; Robert C. Young; Marc E. Lippman

  The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery

  World Journal of Surgery. 1985;9(5):775-785.
  22

• 328.

  1985

  M.E. Lippman

  The NIH Consensus Development Conference on Adjuvant Chemotherapy for Breast Cancer - A commentary

  Breast Cancer Research and Treatment. 1985;6(3):195-200.
  1

• 329.

  1985

  N.E. Davidson; M.E. Lippman

  Combined therapy in advanced breast cancer

  European Journal of Cancer and Clinical Oncology. 1985;21(10):1123-1126.
  0

• 330.

  1985

  M.E. Lippman

  Growth regulation of human breast cancer

  Clinical Research. 1985;33(3):375-382.
  5

• 331.

  1985

  P.A. Findlay; M.E. Lippman; D. Danforth Jr.; H. McDonald; T. d'Angelo; C.R. Gorrell; N.L. Gerber; W. Schain; A.S. Lichter

  Mastectomy versus radiotherapy as treatment for stage I-II breast cancer: A prospective randomized trial at the National Cancer Institute

  World Journal of Surgery. 1985;9(5):671-675.
  4

• 332.

  1984

  D.A. Bronzert; T.J. Triche; P. Gleason; M.E. Lippman

  Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line

  Cancer Research. 1984;44(9):3942-3951.
  1

• 333.

  1984

  S. Scholl; M.E. Lippman

  The estrogen receptor in MCF-7 cells: Evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor

  Endocrinology. 1984;115(4):1295-1301.
  12

• 334.

  1984

  M.E. Lippman

  An assessment of current achievements in the systemic management of breast cancer

  Breast Cancer Research and Treatment. 1984;4(2):69-77.
  3

• 335.

  1984

  M.E. Lippman

  Steroids in malignant diseases: Progress in patient selection

  Hospital Practice. 1984;19(6):93-106.
  0

• 336.

  1984

  A. Kasid; J.S. Strobl; K. Huff; G.L. Greene; M.E. Lippman

  A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells

  Science. 1984;225(4667):1162-1165.
  5

• 337.

  1984

  R. Jakesz; M.E. Lippman

  Is there any autoregulation of growth of breast cancer cells in vitro?

  Langenbecks Archiv fur Chirurgie. 1984;362(SUPPL.):259-263.
  0

• 338.

  1984

  A. Lacroix; G.D. Bonnard; M.E. Lippman

  Modulation of glucocorticoid receptors by mitogenic stimuli, glucocorticoids and retinoids in normal human cultured T cells

  Journal of Steroid Biochemistry. 1984;21(1):73-80.
  9

• 339.

  1984

  J.S. Strobl; A. Kasid; K.K. Huff; M.E. Lippman

  Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells

  Endocrinology. 1984;115(3):1116-1124.
  4

• 340.

  1984

  R.M. Levine; M.E. Lippman

  Breast cancer management: recent advances and recommendations.

  Advances in internal medicine. 1984;29:215-244.
  0

• 341.

  1984

  K.K. Huff; M.E. Lippman

  Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture

  Endocrinology. 1984;114(5):1702-1710.
  9

• 342.

  1984

  R. Jakesz; C.A. Smith; S. Aitken; K. Huff; W. Schuette; S. Shackney; M. Lippman

  Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells

  Cancer Research. 1984;44(2):619-625.
  32

• 343.

  1984

  F. Vignon; M.E. Lippman; H. Nawata; D. Derocq; H. Rochefort

  Induction of two estrogen-responsive proteins by antiestrogens in R₂₇, a tamoxifen-resistant clone of MCF₇ cells

  Cancer Research. 1984;44(5):2084-2088.
  2

• 344.

  1984

  M.E. Lippman; A.S. Lichter; B.K. Edwards; C.R. Gorrell; T. d'Angelo; E.V. DeMoss

  The impact of primary irradiation treatment of localized breast cancer on the ability to administer systemic adjuvant chemotherapy

  Journal of Clinical Oncology. 1984;2(1):21-27.
  2

• 345.

  1984

  M.E. Lippman; A. Kasid

  Role of receptors in mediating steroid hormone effects in human breast cancer

  Cancer Treatment Reports. 1984;68(1):265-279.
  0

• 346.

  1984

  M.E. Lippman; J. Cassidy; M. Wesley; R.C. Young

  A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization

  Journal of Clinical Oncology. 1984;2(1):28-36.
  18

• 347.

  1984

  R.M. Levine; M.E. Lippman

  Relationship between estrogen-receptor proteins and response to chemotherapy in breast cancer

  Cancer Treatment Reports. 1984;68(4):573-576.
  0

• 348.

  1984

  R. Jakesz; M.E. Lippman

  Adjuvant tamoxifen in breast cancer

  Cancer Treatment Reviews. 1984;11(4):321-323.
  0

• 349.

  1984

  M.E. Lippman; A. Buzdar; D.C. Tormey; W.L. McGuire

  Combining endocrine and chemotherapy - Any true benefits?

  Breast Cancer Research and Treatment. 1984;4(4):251-259.
  0

• 350.

  1984

  M.A. Miller; M.E. Lippman; B.S. Katzenellenbogen

  Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells

  Cancer Research. 1984;44(11):5038-5045.
  7

• 351.

  1983

  S.M. Scholl; K.K. Huff; M.E. Lippman

  Antiestrogenic effects of LY 117018 in MCF-7 cells

  Endocrinology. 1983;113(2):611-617.
  21

• 352.

  1983

  K. Seibert; S.M. Shafie; T.J. Triche; J.J. Whang-Peng; S.J. O'Brien; J.H. Toney; K.K. Huff; M.E. Lippman

  Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice

  Cancer Research. 1983;43(5):2223-2239.
  42

• 353.

  1983

  C. Eil; M.E. Lippman; E.V. De Moss; D.L. Loriaux

  Androgen receptor characteristics in skin fibroblasts from men with pubertal macromastia

  Clinical Endocrinology. 1983;19(2):223-230.
  0

• 354.

  1983

  R. Jakesz; A. Kasid; M.E. Lippman

  Continuous estrogen exposure in the rat does not induce loss of uterine estrogen receptor

  Journal of Biological Chemistry. 1983;258(19):11798-11806.
  0

• 355.

  1983

  D.N. Danforth Jr.; L. Tamarkin; R. Do; M.E. Lippman

  Melatonin-induced increase in cytoplasmic estrogen receptor activity in hamster uteri

  Endocrinology. 1983;113(1):81-85.
  8

• 356.

  1983

  D.N. Danforth Jr.; L. Tamarkin; M.E. Lippman

  Melatonin increases oestrogen receptor binding activity of human breast cancer cells

  Nature. 1983;305(5932):323-325.
  23

• 357.

  1983

  R. Jakesz; A. Kasid; G. Greene; M.E. Lippman

  Characteristics of different cytoplasmic and nuclear estrogen receptors appearing with continuous hormonal exposure

  Journal of Biological Chemistry. 1983;258(19):11807-11813.
  2

• 358.

  1983

  S.C. Aitken; M.E. Lippman

  Hormonal regulation of the novo pyrimidine synthesis and ultilization in human breast cancer cells in tissue culture

  Cancer Research. 1983;43(10):4681-4690.
  8

• 359.

  1983

  L.M. Weisenthal; P.L. Dill; N.B. Kurnick; M.E. Lippman

  Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity

  Cancer Research. 1983;43(1):258-264.
  38

• 360.

  1983

  D.C. Tormey; M.E. Lippman; B.K. Edwards; J.G. Cassidy

  Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer

  Annals of Internal Medicine. 1983;98(2):139-144.
  42

• 361.

  1983

  M.E. Lippman

  Efforts to combine endocrine and chemotherapy in the management of breast cancer: Do two and two equal three?

  Breast Cancer Research and Treatment. 1983;3(2):117-127.
  13

• 362.

  1983

  B. Fisher; C. Redmond; A. Brown; D.L. Wickerham; N. Wolmark; J. Allegra; G. Escher; M. Lippman; E. Savlov; J. Wittliff

  Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

  Journal of Clinical Oncology. 1983;1(4):227-241.
  68

• 363.

  1983

  L.A. Zwelling; D. Kerrigan; M.E. Lippman

  Protein-associated intercalator-induced DNA scission is enhanced by estrogen stimulation in human breast cancer cells

  Proceedings of the National Academy of Sciences of the United States of America. 1983;80(20 I):6182-6186.
  1

• 364.

  1983

  J. Whang-Peng; E.C. Lee; C.S. Kao-Shan; K. Seibert; M. Lippman

  Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines

  Journal of the National Cancer Institute. 1983;71(4):687-695.
  16

• 365.

  1983

  M.E. Lippman

  Antiestrogen therapy of breast cancer

  Seminars in Oncology. 1983;10(4 SUPPL. 4):11-19.
  0

• 366.

  1983

  Marie E. Monaco; C.Kent Osborne; Thomas J. Bronzert; William R. Kidwell; Marc E. Lippman

  Characterization of insulin regulation of lipid synthesis in MCF-7 human breast cancer cells

  Breast Cancer Research and Treatment. 1983;3(3):279-285.
  0

• 367.

  1982

  B.A. Silver; A.L. Barlock; M.E. Lippman; T. Anderson; R.I. Fisher

  Phase II trial of chlorozotocin in malignant melanoma, breast cancer, and other solid tumors

  Cancer Treatment Reports. 1982;66(5):1229-1230.
  1

• 368.

  1982

  M.E. Monaco; M.E. Lippman

  A new model system for studying the phosphatidylinositol cycle

  Journal of Cellular Physiology. 1982;112(1):148-153.
  1

• 369.

  1982

  M. Lippman

  Clinical implications of glucocorticoid receptors in human leukemia

  American Journal of Physiology - Endocrinology and Metabolism. 1982;6(2):E103-E108.
  1

• 370.

  1982

  M.T. Chong; M.E. Lippman

  Effects of RNA and ribonuclease on the binding of estrogen and glucocorticoid receptors from MCF-7 cells to DNA-cellulose

  Journal of Biological Chemistry. 1982;257(6):2996-3002.
  4

• 371.

  1982

  M.E. Monaco; P.H. Kohn; W.R. Kidwell; J.S. Strobl; M.E. Lippman

  Vasopressin: Action on WRK-1 rat mammary tumor cells

  Journal of the National Cancer Institute. 1982;68(2):267-270.
  1

• 372.

  1982

  S.C. Aitken; M.E. Lippman

  Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture

  Cancer Research. 1982;42(5):1727-1735.
  10

• 373.

  1982

  K. Cowan; M. Lippman

  Steroid receptors in breast cancer

  Archives of Internal Medicine. 1982;142(2):363-366.
  4

• 374.

  1982

  I.G. Kerr; M.E. Lippman; J. Jenkins; C.E. Myers

  Pharmacology of 13-cis-retinoic acid in humans

  Cancer Research. 1982;42(5):2069-2073.
  27

• 375.

  1982

  D.A. Bronzert; R.B. Hochberg; M.E. Lippman

  Specific cytotoxicity of 16 alpha-[125I]iodoestradiol for estrogen receptor-containing breast cancer cells.

  Endocrinology. 1982;110(6):2177-2182.
  11

• 376.

  1982

  M. Lippman

  Clinical implications of glucocorticoid receptors in human leukemia.

  The American journal of physiology. 1982;243(2):E103-108.
  2

• 377.

  1982

  L. Tamarkin; D. Danforth; A. Lichter; E. DeMoss; M. Cohen; B. Chabner; M. Lippman

  Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer

  Science. 1982;216(4549):1003-1005.
  102

• 378.

  1982

  K. Seibert; M. Lippman

  Hormone receptors in breast cancer

  Clinics in Oncology. 1982;1(3):735-794.
  3

• 379.

  1982

  J. Cassidy; M. Lippman; A. Lacroix; G. Peck

  Phase II trial of 13-cis-retinoic acid in metastatic breast cancer

  European Journal of Cancer and Clinical Oncology. 1982;18(10):925-928.
  20

• 380.

  1982

  K.H. Cowan; M.E. Goldsmith; R.M. Levine; S.C. Aitken; E. Douglass; N. Clendeninn; A.W. Nienhuis; M.E. Lippman

  Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells

  Journal of Biological Chemistry. 1982;257(24):15079-15086.
  13

• 381.

  1982

  M.E. Lippman; J. Cassidy; M. Wesley; R.C. Young

  A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic beast cancer by hormonal synchronization

  Proceedings of the American Society of Clinical Oncology. 1982;Vol. 1:C-305.
  0

• 382.

  1982

  A.S. Lichter; M.E. Lippman; E.V. De Moss

  The influence of primary breast cancer treatment - mastectomy (M) or excisional biopsy plus radiation (E+RT) - on the ability to deliver adjuvant chemotherapy (C)

  Proceedings of the American Society of Clinical Oncology. 1982;Vol. 1:C-312.
  0

• 383.

  1981

  D.A. Bronzert; M.E. Monaco; L. Pinkus; S. Aitken; M.E. Lippman

  Purification and properties of estrogen-responsive cytoplasmic thymidine kinase from human breast cancer

  Cancer Research. 1981;41(2):604-610.
  8

• 384.

  1981

  A. Lacroix; G.D. Anderson; M.E. Lippman

  Binding of retinoids to human fibroblast cell lines and their effects on cell growth

  Annals of the New York Academy of Sciences. 1981;Vol.359:405-406.
  0

• 385.

  1981

  M.E. Lippman; D.C. Tormey; J. Cassidy; B.K. Edwards

  A randomized trial of tamoxifen (TAM) vs. tamoxifen plus fluoxymesterone (FLU) in metastatic breast cancer

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-425.
  0

• 386.

  1981

  M. Chong; M.E. Lippman

  Simultaneous determination of estrogen and progesterone receptors in human breast cancer cytosols

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:43.
  0

• 387.

  1981

  I.G. Kerr; M. Lippman; J. Jenkins; C. Myers

  Clinical pharmacology of 13-cis retinoic acid

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-96.
  0

• 388.

  1981

  M.E. Lippman; H.M.T. Do; R.B. Hochberg

  Specific estrogen receptor binding and biological effects of 16α-Iodoestradiol on human breast cancer cells

  Cancer Research. 1981;41(8):3150-3154.
  7

• 389.

  1981

  K. Cowan; M. Lippman

  Recent progress in breast cancer management. Combined modality (adjuvant) therapy

  Archives of Internal Medicine. 1981;141(8):1055-1059.
  0

• 390.

  1981

  B. Ardalan; J. Macdonald; D. Cooney; M. Lippman; P. Schein

  The potential for clinical application of in vitro assays predicting 5-FU sensitivity in man

  Cancer Treatment Reports. 1981;65(Suppl. 3):57-61.
  1

• 391.

  1981

  M.T. Chong; M.E. Lippman

  Effects of temperature, nucleotides and sodium molybdate on activation and DNA binding of estrogen, glucocorticoid, progesterone and androgen receptors in MCF-7 human cancer cells

  Journal of Receptor Research. 1981;2(5-6):575-600.
  2

• 392.

  1981

  H. Nawata; D. Bronzert; M.E. Lippman

  Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells

  Journal of Biological Chemistry. 1981;256(10):5016-5021.
  20

• 393.

  1981

  L. Tamarkin; M. Cohen; D. Roselle; C. Reichert; M. Lippman; B. Chabner

  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat

  Cancer Research. 1981;41(11 I):4432-4436.
  162

• 394.

  1981

  J.C. Allegra; O. Korat; H.M.T. Do; M. Lippman

  The regulation of progesterone receptor by 17β estradiol and tamoxifen in the ZR-75-1 human breast cancer cell line in defined medium

  Journal of Receptor Research. 1981;2(1):17-27.
  2

• 395.

  1981

  D.A. Bronzert; R.A. Hochberg; M.E. Lippman

  [¹²⁵I]Iodoestradiol is specifically cytotoxic for estrogen responsive breast cancer cells

  Journal of Cell Biology. 1981;91(2 II):No. 12024.
  0

• 396.

  1981

  H. Nawata; M.T. Chong; D. Bronzert; M.E. Lippman

  Estradiol-independent growth of a subline of MCF-7 human breast cancer cells in culture

  Journal of Biological Chemistry. 1981;256(13):6895-6902.
  10

• 397.

  1981

  J. Cassidy; M. Lippman; A. Lacroix

  Phase II trial of 13-CIS-retinoic acid in metastatic breast cancer and other malignancies

  Proceedings of the American Association for Cancer Research. 1981;Vol. 22:C-424.
  0

• 398.

  1980

  H.P. Koeffler; D.W. Golde; M.E. Lippman

  Glucocorticoid sensitivity and receptors in cells of human myelogenous leukemia lines

  Cancer Research. 1980;40(3):563-566.
  3

• 399.

  1980

  R.C. Donehower; J.C. Allegra; M.E. Lippman; B.A. Chabner

  Combined effects of methotrexate and 5-fluoropyrimidine on human breast cancer cells in serum-free culture

  European Journal of Cancer and Clinical Oncology. 1980;16(5):655-661.
  3

• 400.

  1980

  R.B. Everson; M.E. Lippman; E.B. Thompson; W.L. McGuire; J.L. Wittliff; E.R. De Sombre; E.V. Jensen; A. Singhakowinta; S.C. Brooks Jr.; J.P. Neifeld

  Clinical correlations of steroid receptors and male breast cancer

  Cancer Research. 1980;40(4):991-997.
  30

• 401.

  1980

  W.D. DeWys; J.C. Allerga; R. Simon; M.E. Lippman

  A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites

  Cancer Research. 1980;40(7):2423-2427.
  1

• 402.

  1980

  A. Lacroix; M.E. Lippman

  Binding of retinoids to human breast cancer cell lines and their effects on cell growth

  Journal of Clinical Investigation. 1980;65(3):586-591.
  49

• 403.

  1980

  J.C. Allegra; M.E. Lippman; E.B. Thompson; R. Simon; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken; R. Warren

  Estrogen receptor status: An important variable in predicting response to endocrine therapy in metastatic breast cancer

  European Journal of Cancer and Clinical Oncology. 1980;16(3):323-331.
  42

• 404.

  1980

  J.C. Allegra; A. Barlock; K.K. Huff; M.E. Lippman

  Changes in multiple or sequential estrogen receptor determinations in breast cancer

  Cancer. 1980;45(4):792-794.
  25

• 405.

  1980

  M.E. Lippman; J.C. Allegra

  Lack of estrogen receptor associated with an increased response rate to cytotoxic chemotherapy in metastatic breast cancer?

  Recent Results in Cancer Research. 1980;Vol 71:155-161.
  11

• 406.

  1980

  J.C. Allegra; M.E. Lippman

  Estrogen receptor status and the disease-free interval in breast cancer

  Recent Results in Cancer Research. 1980;Vol 71:20-25.
  6

• 407.

  1980

  M.E. Lippman; J.C. Allegra; J.S. Strobl

  A hormone-dependent human breast cancer cell line grown in defined medium

  Recent Results in Cancer Research. 1980;Vol 71:69-79.
  1

• 408.

  1980

  M.T. Chong; M. Lippman

  Purification of estrogen receptors from MCF-7 human breast cancer cells

  Cancer Research. 1980;40(9):3172-3176.
  1

• 409.

  1980

  J.C. Allegra; M.E. Lippman

  The effects of 17β estradiol and tamoxifen on the ZR-75-1 human breast cancer cell line in defined medium

  European Journal of Cancer and Clinical Oncology. 1980;16(8):1007-1015.
  2

• 410.

  1980

  J.S. Strobl; M.E. Monaco; M.E. Lippman

  The role of intracellular equilibria and the effect of antiestrogens on estrogen-receptor dissociation kinetics from perfused cultures of human breast cancer cells

  Endocrinology. 1980;107(2):450-460.
  1

• 411.

  1980

  M.E. Lippman; J.C. Allegra

  Quantitative estrogen receptor analyses: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval

  Cancer. 1980;46(12 SUPPL.):2829-2834.
  39

• 412.

  1980

  W.D. Mercer; M.E. Lippman; T.M. Wahl; C.A. Carlson; D.A. Wahl; D. Lezotte; P.O. Teague

  The use of immunocytochemical techniques for the detection of steroid hormones in breast cancer cells

  Cancer. 1980;46(12 SUPPL.):2859-2868.
  3

• 413.

  1980

  J.P. Neifeld; M.E. Lippman

  Steroid hormone receptors and melanoma

  Journal of Investigative Dermatology. 1980;74(6):379-381.
  14

• 414.

  1980

  M.E. Monaco; W.R. Kidwell; M.E. Lippman

  Neurohypophysial-hormone-responsive cell line derived from a dimethylbenzanthracene-induced rat mammary tumour

  Biochemical Journal. 1980;188(2):437-441.
  3

• 415.

  1980

  A. Lacroix; G.D.L. Anderson; M.E. Lippman

  Retinoids and cultured human fibroblasts. Effects on cell growth and presence of cellular retinoic acid-binding protein

  Experimental Cell Research. 1980;130(2):339-344.
  7

• 416.

  1980

  J.C. Allegra; M.E. Lippman

  Estrogen receptor determination predicts response to tamoxifen therapy

  Recent Results in Cancer Research. 1980;Vol 71:16-19.
  2

• 417.

  1980

  B. Ardalan; J. Macdonald; D. Cooney; M. Lippman; P. Schein

  Prediction of clinical response to 5-fluorouracil-containing chemotherapy: preliminary results of in vitro assay in human breast cancer.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 1980;74:84-90.
  1

• 418.

  1980

  D.C. Tormey; J.M. Bull; M.L. Lippman

  L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: A pilot study

  Cancer Treatment Reports. 1980;64(8-9):1015-1016.
  0

• 419.

  1980

  C. Eil; M.E. Lippman; D.L. Loriaux

  A dispersed-whole cell method for the determination of androgen receptors in human skin fibroblasts

  Steroids. 1980;35(4):389-404.
  9

• 420.

  1980

  J.C. Allegra; M.E. Lippman

  Cancer of the breast.

  New England Journal of Medicine. 1980;302(22):1259.
  0

• 421.

  1979

  H.P. Koeffler; M.E. Lippman; D.W. Golde

  Hormonal responsiveness of two human acute myelogenous leukemia cell lines

  Clinical Research. 1979;27(2):491A.
  0

• 422.

  1979

  M.E. Lippman

  Glucocorticoid receptors and effects in human lymphoid and leukemic cells.

  Monographs on endocrinology. 1979;12:377-397.
  3

• 423.

  1979

  J.C. Allegra; M.E. Lippman

  Chemotherapy for breast cancer

  Comprehensive Therapy. 1979;5(2):13-17.
  0

• 424.

  1979

  M. Lippman

  Interpreting steroid receptor assays.

  Western Journal of Medicine. 1979;130(5):450-451.
  0

• 425.

  1979

  J.C. Allegra; M.E. Lippman; R. Simon; E.B. Thompson; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken; R. Warren

  Association between steroid hormone receptor status and disease-free interval in breast cancer

  Cancer Treatment Reports. 1979;63(8):1271-1277.
  21

• 426.

  1979

  J.S. Strobl; M.E. Lippman

  Prolonged retention of estradiol by human breast cancer cells in tissue culture

  Cancer Research. 1979;39(9):3319-3327.
  9

• 427.

  1979

  M.E. Lippman

  Commentary on the first international congress on hormones and cancer

  Cancer Treatment Reports. 1979;63(7):1143-1144.
  0

• 428.

  1979

  M.T. Chong; M. Lippman

  Purification of estrogen receptors from MCF-7 cells

  Clinical Research. 1979;27(3):582A.
  0

• 429.

  1979

  M.T. Chong; M. Lippman

  Effect of protease inhibitors and substrates on glucocorticoid or estrogen binding to their respective receptors in MCF-7 cells

  Clinical Research. 1979;27(3):572A.
  0

• 430.

  1979

  J.C. Allegra; M.E. Lippman; L. Green; A. Barlock; R. Simon; E.B. Thompson; K.K. Huff; W. Griffin

  Estrogen receptor values in patients with benign breast disease

  Cancer. 1979;44(1):228-231.
  26

• 431.

  1979

  D.W. Golde; N. Bersch; M.E. Lippman; C. Friend

  Detection of glucocorticoid receptors on Friend erythroleukemia cells

  Proceedings of the National Academy of Sciences of the United States of America. 1979;76(7):3515-3517.
  2

• 432.

  1979

  J.C. Allegra; M.E. Lippman; E.B. Thompson; R. Simon; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken; R. Warren

  Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer

  Cancer Research. 1979;39(6 I):1973-1979.
  9

• 433.

  1979

  C.K. Osborne; M.E. Monaco; C.R. Kahn; K. Huff; D. Bronzert; M.E. Lippman

  Direct inhibition of growth and antagonism of insulin action by glucocorticoids in human breast cancer cells in culture

  Cancer Research. 1979;39(7 I):2422-2428.
  17

• 434.

  1979

  J.C. Allegra; M.E. Lippman; E.B. Thompson; R. Simon; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken

  Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer

  Cancer Research. 1979;39(5):1447-1454.
  42

• 435.

  1979

  T.C. Alford; H.M. Do; G.W. Geelhoed; N.T. Tsangaris; M.E. Lippman

  Steroid hormone receptors in human colon cancers

  Cancer. 1979;43(3):980-984.
  42

• 436.

  1979

  M.E. Lippman; J.C. Allegra

  Hormone receptors in breast cancer and response to chemotherapy.

  New England Journal of Medicine. 1979;300(18):1054.
  0

• 437.

  1979

  R. Donehower; J. Allegra; M. Lippman

  Sequence dependent effects of methotrexate (MTX) and 5-fluoropyrimidine (5-FP) in serum-free cultures of human breast cancer

  Proceedings of the American Association for Cancer Research. 1979;Vol. 20:No. 1024.
  0

• 438.

  1978

  C.K. Osborne; M.E. Monaco; M.E. Lippman; C.R. Kahn

  Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long term tissue culture

  Cancer Research. 1978;38(1):94-102.
  28

• 439.

  1978

  J.C. Allegra; M.E. Lippman; E.B. Thompson

  Steroid hormone receptors in human breast cancer

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No. C-118.
  1

• 440.

  1978

  D.A. Bronzert; M.E. Monaco; M.E. Lippman

  Purification and general properties of estrogen responsive cytoplasmic thymidine kinase from human breast cancer

  Federation Proceedings. 1978;37(6):No. 2796.
  0

• 441.

  1978

  J.M. Bull; T. Anderson; M.E. Lippman

  A phase II trial of CIS-dichlorodiamine platinum II (CIS-DDP) in breast and ovarian carcinomas

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:no.345.
  6

• 442.

  1978

  R.I. Fisher; R.C. Young; M.E. Lippman

  Diethylstilbestrol therapy of surgically non-resectable malignant melanoma

  Proceedings of the American Association for Cancer Research. 1978;Vol. 19:No.C-130.
  2

• 443.

  1978

  M. Lippman

  Use of steroids as carriers of cytotoxic agents in breast cancer: estrogens linked with nitrogen mustard groups [proceedings]

  Cancer Treatment Reports. 1978;62(8):1259-1260.
  0

• 444.

  1978

  J.S. Macdonald; M.E. Lippman; P.V. Woolley; P.P. Petrucci; P.S. Schein

  Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm

  Cancer Chemotherapy and Pharmacology. 1978;1(3):135-138.
  3

• 445.

  1978

  M.E. Lippman; J.C. Allegra

  Current concepts in cancer. Receptors in breast cancer

  New England Journal of Medicine. 1978;299(17):930-933.
  11

• 446.

  1978

  G.D. Bonnard; M.E. Lippman

  Induction of glucocorticoid hormone receptors in human cultured T cells

  Schweizerische Medizinische Wochenschrift. 1978;108(41):1603.
  0

• 447.

  1978

  M.E. Lippman; J.C. Heuson; F.M. Muggia

  Problems in the development of cytotoxic moieties linked to hormones

  Cancer Treatment Reports. 1978;62(8):1267-1268.
  0

• 448.

  1978

  M. Cohen; M. Lippman; B. Chabner

  Role of pineal gland in aetiology and treatment of breast cancer

  Lancet. 1978;2(8094):814-816.
  101

• 449.

  1978

  L.W. Engel; N.A. Young; T.S. Tralka; M.E. Lippman; S.J. O'Brien; M.J. Joyce

  Establishment and characterization of three new continuous cell lines derived from human breast carcinomas

  Cancer Research. 1978;38(10):3352-3364.
  132

• 450.

  1978

  M. Cohen; M. Lippman; B. Chabner

  Pineal gland and breast cancer

  Lancet. 1978;2(8104):1381-1382.
  8

• 451.

  1978

  M. Cohen; D. Roselle; B. Chabner; T.J. Schmidt; M. Lippman

  Evidence for a cytoplasmic melatonin receptor

  Nature. 1978;274(5674):894-895.
  30

• 452.

  1978

  M. Lippman

  Summary of additional presentations from the workshop on the use of steroids as carriers of cytotoxic agents in breast cancer

  Cancer Treatment Reports. 1978;62(8):1259-1265.
  0

• 453.

  1978

  M.E. Monaco; M.E. Lippman; R. Knazek; W.R. Kidwell

  Vasopressin stimulation of acetate incorporation into lipids in a dimethylbenz(a)anthracene-induced rat mammary tumor cell line

  Cancer Research. 1978;38(11 II):4101-4104.
  5

• 454.

  1978

  F.W. Graumann; M.E. Lippman

  After Bakke many questions are left unanswered

  Hospitals. 1978;52(22):73-75.
  0

• 455.

  1978

  M.E. Lippman; G. Konior Yarbro; B.G. Leventhal

  Clinical implications of glucocorticoid receptors in human leukemia

  Cancer Research. 1978;38(11 II):4251-4256.
  9

• 456.

  1978

  J.C. Allegra; M.E. Lippman; E.B. Thompson; R. Simon; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken; R. Warren

  Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

  Cancer Treatment Reports. 1978;62(9):1281-1286.
  4

• 457.

  1978

  J.C. Allegra; M.E. Lippman

  Growth of a human breast cancer cell line in serum-free hormone-supplemented medium

  Cancer Research. 1978;38(11 I):3823-3829.
  10

• 458.

  1978

  J.C. Allegra; M.E. Lippman; E.B. Thompson; R. Simon

  An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer

  Cancer Research. 1978;38(11 II):4299-4304.
  9

• 459.

  1978

  M.I. Kaiser-Kupfer; M.E. Lippman

  Tamoxifen retinopathy

  Cancer Treatment Reports. 1978;62(3):315-320.
  67

• 460.

  1978

  M.E. Lippman; J.C. Allegra; E.B. Thompson; R. Simon; A. Barlock; L. Green; K.K. Huff; H.M. Do; S.C. Aitken; R. Warren

  The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

  New England Journal of Medicine. 1978;298(22):1223-1228.
  74

• 461.

  1978

  R. Donehower; J. Allegra; M. Lippman; B. Chabner

  Methotrexate interaction with 5-fluorouracil and 5-fluorodeoxyuridine in serum-free cultures of human breast cancer

  Clinical Research. 1978;26(3):434A.
  0

• 462.

  1978

  R. D'Agata; M.E. Monaco; M.E. Lippman; D.L. Loriaux

  Failure of breast cancer cells in long-term culture to aromatize androstenedione

  Steroids. 1978;31(4):463-470.
  0

• 463.

  1978

  M.E. Monaco; C.K. Osborne; M.E. Lippman

  Insulin stimulates acetyl Co A carboxylase in human breast cancer cells: Possible mechanism of somatotrophic effect of insulin

  Clinical Research. 1978;26(3):439A.
  0

• 464.

  1978

  F.J. Hendler; M.E. Monaco; D. Bronzer; M.E. Lippman

  The stimulatory effects of insulin on macromolecular synthesis in a rat mammary tumor in tissue culture

  Clinical Research. 1978;26(3):436A.
  0

• 465.

  1978

  M.E. Lippman; J.C. Allegra; E.B. Thompson

  Estrogen receptor status predicts response to cytotoxic chemotherapy in metastatic breast cancer

  Clinical Research. 1978;26(3):536A.
  0

• 466.

  1978

  B.A. Chabner; M. Cohen; M. Lippman

  Adjuvant therapy of breast cancer: accomplishments and future course.

  Journal of the American Medical Association. 1978;239(22):2373-2374.
  0

• 467.

  1977

  E.B. Thompson; M.R. Norman; M.E. Lippman

  Steroid hormone actions in tissue culture cells and cell hybrids; their relation to human malignancies

  Recent Progress in Hormone Research. 1977;Vol. 33:571-615.
  1

• 468.

  1977

  M. Menon; C.E. Tananis; M.G. McLoughlin; M.E. Lippman; P.C. Walsh

  The measurement of androgen receptors in human prostatic tissue utilizing sucrose density centrifugation and a protamine precipitation assay

  Journal of Urology. 1977;117(3):309-312.
  0

• 469.

  1977

  E.B. Thompson; D. Aviv; M.E. Lippman

  Variants of HTC cells with low tyrosine aminotransferinase inducibility and apparently normal glucocorticoid receptors

  Endocrinology. 1977;100(2):406-419.
  1

• 470.

  1977

  M.E. Monaco; D.A. Bronzert; D.C. Tormey; P. Waalkes; M.E. Lippman

  Casein production by human breast cancer

  Cancer Research. 1977;37(3):749-754.
  1

• 471.

  1977

  R.A. Knazek; M.E. Lippman; H.C. Chopra

  Formation of solid human mammary carcinoma in vitro

  Journal of the National Cancer Institute. 1977;58(2):419-422.
  2

• 472.

  1977

  M. Lippman; M.E. Monaco; G. Bolan

  Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture

  Cancer Research. 1977;37(6):1901-1907.
  30

• 473.

  1977

  J.P. Neifeld; M.E. Lippman; D.C. Tormey

  Steroid hormone receptors in normal human lymphocytes. Induction of glucocorticoid receptor activity by phytohemagglutinin stimulation

  Journal of Biological Chemistry. 1977;252(9):2972-2977.
  17

• 474.

  1977

  G.S. Konior; M.E. Lippman; G.E. Johnson

  Glucocorticoid receptors in acute non lymphocytic leukemia

  Proceedings of the American Association for Cancer Research. 1977;Vol.18:No.937.
  0

• 475.

  1977

  M.E.C.K.R.N. ippman Osborne Knazek Young

  In vitro model systems for the study of hormone dependent human breast cancer

  New England Journal of Medicine. 1977;296(3):154-159.
  14

• 476.

  1977

  M. Lippman; K. Huff; G. Bolan

  Progesterone and glucocorticoid interactions with receptor in breast cancer cells in long term tissue culture

  Annals of the New York Academy of Sciences. 1977;Vol.286:101-115.
  2

• 477.

  1977

  M.E. Monaco; C. Kent Osborne; M.E. Lippman

  Insulin stimulation of fatty acid synthesis in human breast cancer cells. Brief communication

  Journal of the National Cancer Institute. 1977;58(6):1591-1593.
  0

• 478.

  1977

  M. Lippman; R. Barr

  Glucocorticoid receptors in purified subpopulations of human peripheral blood lymphocytes

  Journal of Immunology. 1977;118(6):1977-1981.
  20

• 479.

  1977

  M.E. Monaco; M.E. Lippman

  Insulin stimulation of fatty acid synthesis in human breast cancer in long term tissue culture

  Endocrinology. 1977;101(4):1238-1246.
  2

• 480.

  1977

  S.C. Aitken; M.E. Lippman

  A simple computer program for quantitation and Scatchard analysis of steroid receptor proteins

  Journal of Steroid Biochemistry. 1977;8(1):77-93.
  0

• 481.

  1977

  G.S. Konior Yarbro; M.E. Lippman; G.E. Johnson; B.G. Leventhal

  Glucocorticoid receptors in subpopulations of childhood acute lymphocytic leukemia

  Cancer Research. 1977;37(8):I.
  2

• 482.

  1977

  R.C. Young; M. Lippman; V.T. DeVita

  Perspectives in the treatment of breast cancer: 1976

  Annals of Internal Medicine. 1977;86(6):784-798.
  0

• 483.

  1977

  M. Lippman; M.E. Monaco; G. Bolan

  Estriol stimulates the growth of human breast cancer in tissue culture

  Clinical Research. 1977;25(3):409A.
  0

• 484.

  1977

  W.R. Kidwell; M. Lippman; M. Monaco

  Hormonal stimulation of lipid synthesis in established rat mammary tumor cells

  Proceedings of the American Association for Cancer Research. 1977;Vol. 18:No. 542.
  0

• 485.

  1976

  D.C. Tormey; R.M. Simon; M.E. Lippman; J.M. Bull; C.E. Myers

  Evaluation of tamoxifen dose in advanced breast cancer: A progress report

  Cancer Treatment Reports. 1976;60(10):1451-1459.
  18

• 486.

  1976

  M. Lippman; G. Bolan; K. Huff

  Interactions of antiestrogens with human breast cancer in long term tissue culture

  Cancer Treatment Reports. 1976;60(10):1421-1429.
  8

• 487.

  1976

  D.C. Tormey; G. Falkson; E. Perlin; J. Bull; J. Blom; M.E. Lippman

  Evaluation of an intermittent schedule of dibromodulcitol in breast cancer

  Cancer Treatment Reports. 1976;60(11):1593-1596.
  2

• 488.

  1976

  M. Lippman; G. Bolan; M. Monaco; L. Pinkus; L. Engel

  Model systems for the study of estrogen action in tissue culture

  Journal of Steroid Biochemistry. 1976;7(11-12):1045-1051.
  7

• 489.

  1976

  J.P. Neifeld; M.E. Lippman; D.C. Tormey

  Induction of glucocorticoid receptor activity in human peripheral blood lymphocytes of PHA stimulation

  Clinical Research. 1976;24(3):429A.
  0

• 490.

  1976

  J.P. Neifeld; M.C. Lippman; R.I. Fisher

  Receptors for steroid hormones in human melanoma

  Surgical Forum. 1976;Vol. 27:108-110.
  2

• 491.

  1976

  M. Lippman; G. Bolan; K. Huff

  The effects of estrogens and antiestrogens on hormone responsive human breast cancer in long term tissue culture

  Cancer Research. 1976;36(12):4595-4601.
  211

• 492.

  1976

  M. Lippman; G. Bolan; K. Huff

  The effects of glucocorticoids and progesterone on hormone responsive human breast cancer in long term tissue culture

  Cancer Research. 1976;36(12):4602-4609.
  28

• 493.

  1976

  M. Lippman; G. Bolan; K. Huff

  The effects of androgens and antiandrogens on hormone responsive human breast cancer in long term tissue culture

  Cancer Research. 1976;36(12):4610-4618.
  47

• 494.

  1976

  D. Tormey; M. Lippman; J. Bull; C. Myers

  Evaluation of tamoxifen dose in advanced breast cancer

  Proceedings of the American Association for Cancer Research. 1976;Vol.17:No.C-157.
  0

• 495.

  1976

  C.K. Osborne; M.E. Monaco; M.E. Lippman

  Insulin receptors in human breast cancer: relationship of binding, degradation and biological activity

  Diabetes. 1976;25(sup.1):No.237.
  0

• 496.

  1976

  M. Lippman; K. Huff

  A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay

  Cancer. 1976;38(2):868-874.
  14

• 497.

  1976

  J.P. Neifeld; J.N. Ingle; D.C. Tormey; M.E. Lippman; S.D. Richman; L.L. Michaelis

  Mediastinoscopy. A diagnostic aid in metastatic carcinoma of the breast

  Cancer. 1976;37(4):1973-1976.
  0

• 498.

  1976

  R.I. Fisher; J.P. Neifeld; M.E. Lippman

  Oestrogen receptors in human malignant melanoma

  Lancet. 1976;2(7981):337-338.
  44

• 499.

  1976

  Marc Lippman

  Steroid hormone receptors in human malignancy

  Life Sciences. 1976;18(2):143-152.
  3

• 500.

  1976

  C.K. Osborne; G. Bolan; M.E. Monaco; M.E. Lippman

  Hormone responsive human breast cancer in long term tissue culture: effect of insulin

  Proceedings of the National Academy of Sciences of the United States of America. 1976;73(12):4536-4540.
  80

• 501.

  1975

  M.E. Lippman; S. Perry; E.B. Thompson

  Glucocorticoid binding proteins in myeloblasts of acute myelogenous leukemia

  American Journal of Medicine. 1975;59(2):224-227.
  1

• 502.

  1975

  J.C. Pita Jr.; M.E. Lippman; E.B. Thompson; D.L. Loriaux

  Interaction of spironolactone and digitalis with the 5α dihydrotestosterone (DHT) receptor of rat ventral prostate

  Endocrinology. 1975;97(6):1521-1527.
  7

• 503.

  1975

  C.E. Myers; M.E. Lippman; H.M. Eliot; B.A. Chabner

  Competitive protein binding assay for methotrexate

  Proceedings of the National Academy of Sciences of the United States of America. 1975;72(9):3683-3686.
  2

• 504.

  1975

  E.B. Thompson; C.U. Anderson; M.E. Lippman

  Serum free growth of HTC cells containing glucocorticoid and insulin inducible tyrosine aminotransferase and cytoplasmic glucocorticoid receptors

  Journal of Cellular Physiology. 1975;86(2 II):403-411.
  0

• 505.

  1975

  M.E. Lippman; G. Bolan; K. Huff

  Human breast cancer responsive to androgen in long term tissue culture

  Nature. 1975;258(5533):339-341.
  5

• 506.

  1975

  M.E. Lippman; G. Bolan

  Oestrogen responsive human breast cancer in long term tissue culture

  Nature. 1975;256(5518):592-593.
  77

• 507.

  1975

  G. Bolan; K. Huff; M.E. Lippman

  Glucocorticoids inhibit human breast cancer in long term tissue culture

  Journal of Cell Biology. 1975;67(2 II):No.71.
  0

• 508.

  1975

  M. Lippman

  Hormone dependent human breast cancer in tissue culture

  Clinical Research. 1975;23(3):425A.
  0

• 509.

  1974

  E.B. Thompson; M.E. Lippman

  Mechanism of action of glucocorticoids

  Metabolism: Clinical and Experimental. 1974;23(2):159-202.
  33

• 510.

  1974

  S.S. Yang; M.E. Lippman; E.B. Thompson

  Transfer ribonucleic acid in hepatoma tissue culture cells. I. Induction in vivo by dexamethasone phosphate of phenylalanine accepting activity

  Endocrinology. 1974;94(1):254-261.
  0

• 511.

  1974

  M.E. Lippman; S.S. Yang; E.B. Thompson

  Transfer ribonucleic acid in hepatoma tissue culture cells. II. Dexamethasone phosphate induction of tRNA(phe) analyzed under cell free conditions

  Endocrinology. 1974;94(1):262-266.
  0

• 512.

  1974

  M.E. Lippman; B.O. Wiggert; G.J. Chader; E.B. Thompson

  Glucocorticoid receptors. Characteristics, specificity, and ontogenesis in the embryonic chick neural retina

  Journal of Biological Chemistry. 1974;249(18):5916-5917.
  4

• 513.

  1974

  M.E. Lippman; S. Perry; E.B. Thompson

  Cytoplasmic glucocorticoid binding proteins in glucocorticoid unresponsive human and mouse leukemic cell lines

  Cancer Research. 1974;34(7):1572-1576.
  1

• 514.

  1974

  M. Lippman; E.B. Thompson

  The role of transcortin in glucocorticoid mediated enzyme induction: tyrosine aminotransferase induction in hepatoma tissue culture cells

  Journal of Steroid Biochemistry. 1974;5(5):461-465.
  3

• 515.

  1974

  E.B. Thompson; M.E. Lippman

  Glucocorticoid binding proteins in leukemic cells

  Proceedings of the American Association for Cancer Research. 1974;Vol. 15:No. 481.
  0

• 516.

  1974

  M.E. Lippman; E.B. Thompson

  Steroid receptors and the mechanism of the specificity of glucocorticoid responsiveness of somatic cell hybrids between hepatoma tissue culture cells and mouse fibroblasts

  Journal of Biological Chemistry. 1974;249(8):2483-2488.
  0

• 517.

  1973

  M. Lippman; R. Halterman; S. Perry; B. Leventhal; E.B. Thompson

  Glucocorticoid binding proteins in human leukaemic lymphoblasts

  NATURE NEW BIOL. 1973;242(118):157-158.
  2

• 518.

  1973

  M.E. Lippman; R.H. Halterman; B.G. Leventhal; S. Perry; E.B. Thompson

  Glucocorticoid binding proteins in human acute lymphoblastic leukemic blast cells

  Journal of Clinical Investigation. 1973;52(7):1715-1725.
  13

• 519.

  1973

  M.E. Lippman; E.B. Thompson

  Differences between cytoplasmic glucocorticoid binding proteins shown by heterogeneity of nuclear acceptor sites

  Nature. 1973;246(5432):352-355.
  0

• 520.

  1973

  M.E. Lippman; E.B. Thompson

  Drug combinations in malignant disease.

  Lancet. 1973;1(7813):1198.
  0

• 521.

  1972

  R.G. Graw Jr.; R.A. Yankee; G.N. Rogentine; B.G. Leventhal; G.P. Herzig; R.H. Halterman; C.B. Merritt; M.H. McGinniss; G.R. Krueger; J. Whang-Peng; et al.

  Bone marrow transplantation from HL-A matched donors to patients with acute leukemia. Toxicity and antileukemic effect.

  Transplantation. 1972;14(1):79-80.
  2

• 522.

  1972

  M.E. Lippman; S.C. Finch

  A quantitative study of muramidase distribution in normal and nitrogen mustard-treated rats.

  Yale Journal of Biology and Medicine. 1972;45(5):463-470.
  1

• 523.

  1972

  M. Lippman; R. Zager; E.S. Henderson

  High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia.

  Cancer chemotherapy reports. Part 1. 1972;56(6):755-760.
  1

• 524.

  1967

  R.B. Yules; M.E. Lippman; D.X. Freedman

  Alcohol administration prior to sleep. The effect on EEG sleep stages.

  Archives of General Psychiatry. 1967;16(1):94-97.
  23